Next Article in Journal
Validation of the Finite Element Model versus Biomechanical Assessments of Dental Implants and Total Knee Replacements
Next Article in Special Issue
GAN-Based Approach for Diabetic Retinopathy Retinal Vasculature Segmentation
Previous Article in Journal
Future of Endoscopic Spine Surgery: Insights from Cutting-Edge Technology in the Industrial Field
Previous Article in Special Issue
Prediction of Contaminated Areas Using Ultraviolet Fluorescence Markers for Medical Simulation: A Mobile Phone Application Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Artificial Intelligence Applications for Osteoporosis Classification Using Computed Tomography

by
Wilson Ong
1,*,†,
Ren Wei Liu
1,†,
Andrew Makmur
1,2,
Xi Zhen Low
1,2,
Weizhong Jonathan Sng
1,2,
Jiong Hao Tan
3,
Naresh Kumar
3 and
James Thomas Patrick Decourcy Hallinan
1,2
1
Department of Diagnostic Imaging, National University Hospital, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore
2
Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore 117597, Singapore
3
University Spine Centre, Department of Orthopaedic Surgery, National University Health System, 1E Lower Kent Ridge Road, Singapore 119228, Singapore
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Bioengineering 2023, 10(12), 1364; https://doi.org/10.3390/bioengineering10121364
Submission received: 20 October 2023 / Revised: 21 November 2023 / Accepted: 23 November 2023 / Published: 27 November 2023
(This article belongs to the Special Issue Computer Vision and Machine Learning in Medical Applications)

Abstract

:
Osteoporosis, marked by low bone mineral density (BMD) and a high fracture risk, is a major health issue. Recent progress in medical imaging, especially CT scans, offers new ways of diagnosing and assessing osteoporosis. This review examines the use of AI analysis of CT scans to stratify BMD and diagnose osteoporosis. By summarizing the relevant studies, we aimed to assess the effectiveness, constraints, and potential impact of AI-based osteoporosis classification (severity) via CT. A systematic search of electronic databases (PubMed, MEDLINE, Web of Science, ClinicalTrials.gov) was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 39 articles were retrieved from the databases, and the key findings were compiled and summarized, including the regions analyzed, the type of CT imaging, and their efficacy in predicting BMD compared with conventional DXA studies. Important considerations and limitations are also discussed. The overall reported accuracy, sensitivity, and specificity of AI in classifying osteoporosis using CT images ranged from 61.8% to 99.4%, 41.0% to 100.0%, and 31.0% to 100.0% respectively, with areas under the curve (AUCs) ranging from 0.582 to 0.994. While additional research is necessary to validate the clinical efficacy and reproducibility of these AI tools before incorporating them into routine clinical practice, these studies demonstrate the promising potential of using CT to opportunistically predict and classify osteoporosis without the need for DEXA.

1. Introduction

Osteoporosis is characterized by low bone mineral density (BMD) and microstructural degradation of the bone tissue [1], rendering bones more brittle and susceptible to fractures. According to a recent meta-analysis conducted in 2021 by Salari et al. [2], the global prevalence of osteoporosis in women was 23.1%, while the prevalence of osteoporosis among men was 11.7%, with the prevalence varying greatly between different countries [3]. The main complication of osteoporosis is fragility fractures, which are frequently linked to heightened mortality and morbidity [4,5,6]. Substantial physical, psychological, social, and economic repercussions due to significant osteoporotic fractures have been extensively documented in prior studies [7,8,9,10]. These include reduced quality of life [11], increased healthcare costs [12,13], increased mortality risks, limited physical activity, and loss of independence [14,15]. As a result, the early diagnosis of osteoporosis is crucial for timely intervention and the prevention of osteoporotic fractures and their complications [16,17,18].
Dual-energy X-ray absorptiometry (DEXA) is endorsed by the World Health Organization (WHO) as the gold standard for evaluating BMD and diagnosing osteoporosis [19,20,21]. The BMD values derived from DEXA are converted into T-scores, which are calculated on the basis of the difference between the individual’s BMD and reference population mean divided by the standard deviation of the population mean [22]. A T-score of −2.5 or less indicates osteoporosis, and a T-score between −1.0 and −2.5 is defined as osteopenia [23,24].
While DEXA remains the most commonly utilized quantitative radiologic method for assessing bone mass [25,26] due to its non-invasiveness and cost-efficiency [27,28,29], certain limitations must be considered. Firstly, DEXA’s diagnostic capability is mainly confined to BMD alone [30,31] and suboptimal screening rates have been reported [32,33]. Additionally, it is constrained by its planar technique (two-dimensional measurement) for assessing and quantifying BMD and predicting fracture risk [34,35]. Moreover, DEXA measurements are sensitive to degenerative changes, leading to the potential overestimation of BMD [36,37,38], and the presence of overlying structures (such as atherosclerosis [39]) or morphological abnormalities (post-laminectomy, metallic implants, etc. [40,41,42]) may also impact BMD measurements.
Dual-energy computed tomography (DECT) is a radiological technique that can be used for measuring bone mineral density (BMD). The concept of using dual-energy computed tomography (DECT) to evaluate BMD was first studied more than four decades ago [43]. DECT measures the attenuation of X-rays as they pass through the bone. This attenuation is affected by the density of the tissue, and by acquiring images at different energy levels (typically high and low energy levels), DECT can calculate the BMD of the bone in the region of interest [44,45].
DECT has shown similar sensitivity to the gold standard DEXA for the evaluation of bone density and the prediction of associated osteoporotic fractures [46,47,48]. For instance, Booz et al. [45] reported a DECT sensitivity of up to 96.0% and a specificity of 93.0% in detecting osteoporosis compared with DEXA. Another study by Gruenewald et al. [49] found that DECT-derived BMD exhibited a sensitivity of 85.5% and a specificity of 89.2% in predicting osteoporotic-associated fractures. In addition to its diagnostic accuracy, DECT offers distinct advantages, including its capability to assess extended dimensional information [50] and to evaluate local changes in BMD. Notably, DECT excels in accurately distinguishing between trabecular and cortical bone, providing valuable insights into the trabecular bone microstructure, such as local parameters like trabecular spacing and connectivity. These capabilities are crucial for the comprehensive evaluation of bone health [51,52]. However, DECT has not been widely used to screen for osteoporosis due to the high radiation dose [53,54], which is a limitation of its unique diagnostic capabilities [55]. Furthermore, it often requires an in-scan calibration phantom [56,57,58], which makes it difficult to use it for routine BMD measurements in CT scans acquired for indications other than BMD measurements [59] or the retrospective measurement of BMD [60,61].
One potential future innovation is to evaluate bone mineral density (BMD) exclusively through CT scans, eliminating the need for DEXA or DECT scans. This could have significant clinical implications for several reasons: first, it allows for the simultaneous provision of both anatomical visualization and quantitative data [62,63]; second, individuals who have undergone CT scans as part of routine health assessments or other medical indications could be screened automatically [64,65,66]; third, a vast CT database could be leveraged to identify patients that may require referral and treatment [67,68,69]; and finally, this approach could lead to decreased expenses [70] and radiation exposure [71,72,73], as the patient may not need to undergo further radiological investigations before the diagnosis and treatment of osteoporosis.
BMD values extracted from CT images were initially determined by establishing a positive correlation between attenuation values or radiodensity (expressed as Hounsfield Units (HUs)) measured at various locations on CT scans and corresponding BMD values obtained from DEXA dating back as early as 2013 [74]. Subsequently, many other studies [67,75,76,77,78] confirmed the feasibility of trabecular HU values for screening osteoporosis on CT. However, most studies have involved manual or semi-automatic segmentation, which is often time-consuming due to the required manual input and/or computing power [79] and other limitations [80,81,82].
With the recent advent of artificial intelligence (AI) technology, machine learning and deep learning models have applications in osteoporosis detection and classification. These applications encompass osteoporosis risk prediction [83,84,85] and fracture risk assessment [86,87,88,89]. Notably, AI has been employed to streamline the complex processing of CT images and enhance automated segmentation [90,91,92], which has been utilized for BMD measurement and classification in multiple studies [93,94,95,96,97,98,99,100,101,102,103]. Radiomics involves the extraction and analysis of a large number of quantitative features from medical images, such as CT scans. These features capture intricate details in the images (beyond the human eye), enabling a more comprehensive understanding of the underlying tissue characteristics. Radiomics and texture analysis with deep learning techniques have also been used to analyze trabecular bone structure in CT images, providing insights into bone quality and microstructure that are not attainable through DEXA or visual measurements alone, thereby improving the accuracy of diagnosing osteoporosis [104,105]. While many studies have focused on the use of AI for classifying or detecting osteoporosis, they often suffer from limitations, such as single-center designs, limited patient samples, and a lack of validation in real clinical settings.
While several studies in the literature have examined the use of AI to classify osteoporosis in CT images, these studies exhibit significant variation and heterogeneity. A literature gap exists because no studies have systematically consolidated and synthesized these varied research efforts for a comprehensive analysis and summary. Hence, this review article aims to provide an overview of the available evidence on the effectiveness and value of AI techniques in diagnosing osteoporosis and classifying BMD using CT imaging. In this study, our classification of BMD was defined as the severity of osteoporosis, specifically distinguishing between normal BMD and low BMD (including osteopenia and osteoporosis) on the basis of the WHO definition derived from the T-score.

2. Materials and Methods

2.1. Literature Search Strategy

A systematic search of the major electronic databases (PubMed, MEDLINE, Web of Science, and ClinicalTrials.gov) was conducted in concordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using keywords and/or medical subject headings (MeSH) for the following key terms: (“Artificial intelligence” OR “AI” OR “deep learning” OR “machine learning” OR “convolutional neural network*” OR “neural network” OR “radiomics”) AND (“osteoporosis” OR “osteopenia” OR “osteopaenia” OR (“bone” AND “mineral” AND “density”) OR “BMD”) AND (“DEXA” OR “absorptiometry”) AND (“CT” OR (“Computed” AND “Tomography”)). Two authors (W.O. and R.L.) performed independent reviews of the collected references and selected the appropriate studies for detailed full-text screening. The last date of the reference and literature search was 14 August 2023. Any potential conflicts were resolved by consensus or by appeal to a third author (J.T.P.D.H).

2.2. Study Screening and Selection Criteria

No specific limitations were set for the reference and literature search. The primary inclusion criteria encompassed scientific studies that utilized radiomics techniques, artificial intelligence (AI), or deep learning to classify osteoporosis in a diverse range of CT studies and compared their results to those of conventional DXA studies when possible. Articles excluded from further analysis comprised case reports, editorial correspondence (such as letters, commentaries, and opinion pieces), and review articles. Publications focusing on non-imaging radiomics techniques or articles that did not employ AI technology to classify osteoporosis from CT images were also excluded from the analysis.

2.3. Data Extraction and Reporting

All selected research articles were retrieved and compiled into a spreadsheet using Microsoft Excel Version 16.78.3 (Microsoft Corporation, Washington, DC, USA). Information gathered from the individual research articles included:
  • Research article details: complete authorship, date of journal or publication, and journal name;
  • Main clinical use: classify osteoporosis (either normal vs. abnormal BMD or normal vs. osteopenia vs. osteoporosis);
  • Research study details: type of study, patient or imaging modality, body parts scanned, and area of bone segmented for analysis (e.g., internal or external data sets);
  • Machine learning techniques used: radiomics, artificial or convolutional neural networks, etc.;
  • Performance compared with DEXA: for example, the sensitivity, specificity, accuracy, correlation coefficients, and AUCs were obtained when possible.

3. Results

3.1. Search Results

The preliminary search of the main electronic medical databases (Figure 1) identified a total of 87 relevant articles, which were screened using the aforementioned criteria. This screening led to the initial exclusion of eight publications, and the remaining 79 articles underwent further full-text analysis to determine inclusion. Upon detailed analysis of the text, a further 48 publications were removed, as they either did not focus on the classification of osteoporosis or did not utilize AI methods. An additional eight articles were included after manually reviewing the bibliography of the selected articles. Overall, this culminated in a total of 39 articles (Figure 1) for in-depth analysis. The key findings were compiled and summarized in this review (Table 1). Most studies lacked detailed data to create 2 × 2 contingency tables, and hence a formal meta-analysis could not be performed.
Our search identified that of the 39 studies, 22 (56.4%) focused on unenhanced CT, whereas the remaining 17 (43.5%) investigated a combination of enhanced and unenhanced CT studies. Regarding the types of CT studies analyzed, 18 (46.1%) utilized CT abdomen and/or pelvis scans or related CTs encompassing the lumbar spine. Additionally, six (15.4%) studies were centered on CT scans of the thorax, including low-dose-screening CT. Two (5.1%) studies concentrated on CT coronary artery calcium scoring (CTCA), one of which also incorporated low-dose CT thorax in its analysis. A total of 10 (25.6%) studies were conducted on spine CTs, including one on the cervical spine and two on the thoracolumbar spine; the remainder were primarily on the lumbar/lumbosacral spine. The remaining 3/39 (7.7%) studies pertained to CTs of extremities or areas that were not specified. The majority of studies (21/39, 53.8%) analyzed one or more lumbar vertebrae to classify osteoporosis, while 6/39 (15.4%) focused on the thoracic vertebrae, 3/39 (7.7%) focused on the thoracolumbar vertebrae, and 1/39 (2.6%) focused on the cervical vertebrae. The remaining 4/39 studies (10.2%) assessed other non-axial bones, such as the knees, ribs, and wrists, while 2/39 (5.1%) analyzed soft tissues/muscles to classify osteoporosis.
The overall accuracy, sensitivity, and specificity of AI in classifying osteoporosis ranged from 61.8% to 99.4%, 41.0% to 100.0%, and 31.0% to 100.0% respectively, with AUCs ranging from 0.582 to 0.994. Of note, studies with two-label classification (normal versus abnormal BMD) achieved relatively higher performance in general compared with studies with three-label classification (normal vs. osteopenia vs. osteoporosis). Subdividing the analyzed regions showed that features from the lumbar vertebra appeared to achieve the highest AUC of 0.994. This is likely because binary classification is inherently simpler for AI models to handle. The model only needs to decide between two classes, which can result in a more straightforward decision boundary [106]. Furthermore, it is easier for AI models to identify and learn discriminative features when distinguishing between normal and abnormal BMD. In three-label classification, the model must discern finer distinctions, which can be more challenging and may require a larger, more complex model [107]. It is crucial to stress that the choice between binary (two-label) and ternary (three-label) classification should be guided by the specific clinical or research objectives. While binary classification may enhance accuracy, ternary classification can provide more intricate clinical insights and guide nuanced treatment decisions. Finally, it is worth noting that studies that have focused on the cervical and thoracic vertebrae have demonstrated only a moderate degree of correlation (r = 0.270 to 0.670) in contrast to studies encompassing the lumber vertebra (r = 0.582–0.911). The rest of the results for various subgroups are summarized in Table 2.

3.2. Artificial Intelligence

Artificial intelligence, often abbreviated as AI, involves harnessing the computational abilities of machines to carry out tasks resembling human activities [108]. This encompasses utilizing specific inputs to create outcomes that hold potential additional value [109]. Recent advancements in medical imaging alongside the accumulation of significant quantities of digital images and reports [110,111] have ignited increased worldwide interest in implementing AI in the medical imaging domain [112]. Initially conceived to aid radiologists in identifying and evaluating potential irregularities, both AI and computer-aided diagnostic (CAD) systems focus on amplifying efficiency, enhancing detection rates, and minimizing errors [113,114]. As a result, dedicated initiatives are striving to enhance AI’s diagnostic capabilities and optimize its efficiency for seamless integration into clinical practice. The emergence of convolutional neural networks, inspired by the mechanisms of the human brain, has introduced a range of computational learning models primarily centered around machine learning (ML) and deep learning (DL) algorithms [115]. These models have played a pivotal role in propelling the widespread adoption of AI in radiology.

3.3. Machine Learning, Deep Learning, and Radiomics

Machine learning (ML) is a branch of artificial intelligence (AI) that involves training models to make predictions on the basis of existing datasets. These models use their learned knowledge to perform tasks on new, unfamiliar data. To apply ML, data inputs are collected and labeled by experts or extracted using computational methods. Supervised ML models learn from data labeled by human experts to make predictions or classify information, while unsupervised models learn from unlabelled data to uncover patterns and relationships within datasets. Unsupervised models can be used to represent datasets more efficiently and understand their inherent structures. This representation can be a preliminary step before training a supervised model, potentially enhancing its performance.
Deep learning (DL), a subset of ML (Figure 2), mimics the structure of neural networks in the brain. It employs artificial neural networks with multiple hidden layers to solve complex problems. These hidden layers enable the system to continuously learn and improve its performance by incorporating new knowledge. Unlike traditional ML, which requires manual extraction of features from input images, DL methods learn features directly from input images using multilayer neural networks like convolutional neural networks (CNNs). This approach allows DL systems to not only map image features to outputs but also learn the features themselves. Examples of DL outputs include image categories (classification), object locations (detection), and pixel labels (segmentation). Deep learning has given rise to the field of radiomics, which entails extracting a multitude of quantitative features from medical images, including CT scans, to unveil hidden patterns through computational analysis. In the context of bone health, radiomics employing deep learning techniques has the potential to identify imaging features related to important pathological and histological characteristics of bone trabeculae. These features can surpass human diagnostic capabilities and potentially outperform conventional imaging methods. The primary machine learning methods in use are radiomics-based feature analysis (Figure 3), which involves manually designed feature extraction integrated into deep learning training datasets [116], and convolutional neural networks (CNN), which automatically extract valuable image features to classify data directly from input images [117]. CNNs enable the identification of diagnostic patterns and features that exceed human capacity and have applications in osteoporosis diagnosis and classification [118,119].

3.4. General Workflow of BMD Classification in CT

The main methods for extracting valuable bone mineral density (BMD) information from CT images involve the conversion of Hounsfield Units (HUs) measured within the bones [97,98,99]. The HU is a relative quantitative measure of radiodensity used in CT scans to quantify the density of specific tissues or substances within the body. It provides information about the attenuation of X-rays as they pass through the tissue, with calibrated values defined by the densities of air and water as reference points.
After deriving HU values from bones, BMD values can be computed using two main approaches:
  • Phantom-Based Calibration: This method involves placing phantoms containing known densities (such as dipotassium phosphate or calcium hydroxyapatite density rods) beneath the subject during scan acquisition [62,101]. These phantoms are used to calibrate measured HU values to BMD through linear equations. One challenge is that phantom placement is not routinely performed in clinical CT scans [102]. However, this challenge can be overcome by scanning the density phantom asynchronously using the same scanner and scan protocol but without the patient present.
  • Phantomless Internal Calibration: In this approach, the HU peak values of internal reference regions, such as skeletal muscle and adipose tissue, are used. The reference BMD density values for these internal references are determined using phantom-calibrated scans from a cohort of patients [103]. These values are then extrapolated to create a standard calibration curve for converting the trabecular HU to BMD [104,105] through scan-specific equations.
Another reported method for determining BMD from CT images involves applying HU thresholds for osteoporosis screening [48,61,106,107,108]. However, this method lacks reliability due to HU sensitivity to X-ray energy, beam hardening artifacts, positioning, and hardware-related variations, including different scan models and protocols [109,110,111].
To enhance BMD prediction and classification, artificial intelligence (AI) and deep learning methods are increasingly employed. These methods extract imaging data, including CT attenuation (HU) of bones and texture features, to create models [112,113]. The standard process for developing an AI model involves image acquisition and data selection, segmentation, the extraction of image features within specified regions of interest (ROIs), exploratory analysis with feature selection, and building the model [114,115]. The models are validated using test sets, ideally comprising both internal and external data, to assess their performance and generalizability [116]. The two primary machine learning methods used are:
  • Feature-Based Imaging Feature Analysis: This approach involves manually extracting various features and incorporating them into a training set for AI-based imaging classification [117].
  • Deep Learning-Based Analysis (e.g., CNNs): CNNs employ deep learning to automatically extract valuable imaging features by learning patterns directly from input images [118]. This enables the detection and processing of distinct diagnostic patterns and imaging features that go beyond what a human reader can accomplish [120], potentially improving BMD classification.
Table 1. Key characteristics of the selected articles.
Table 1. Key characteristics of the selected articles.
AuthorsArtificial Intelligence MethodPublication YearMain ObjectivesTitle of JournalMain Type of CTAreas SampledPerformance
Yasaka K. et al. [66]CNN 2020Predict osteoporosisEuropean RadiologyUnenhanced CT of abdomenL1 vertebrar  =  0.852 (p  <  0.001), AUC = 0.965 (internal validation) 0.840 (p  <  0.001), AUC = 0.970 (external validation)
Kang J.W. et al. [61]ResNet-101v2, CNN2023Classify osteoporosisFrontiers in PhysiologyUnenhanced CT of abdomenL1 vertebrar = 0.900
F1 score = 0.875
Uemura K. et al. [120] Computer-aided system 2023Classify osteoporosisArchives of OsteoporosisUnenhanced CT of abdomenAxial slice of the L1 vertebra (L1-vBMD)
Axial slices of L1–L4 (CT-vBMD)
Coronal L1–L4 (CT-aBMD)
r = 0.364, AUC = 0.582 (L1-vBMD); r = 0.456, AUC = 0.657 (CT-vBMD); r = 0.911, AUC = 0.941 (CT-aBMD)
Savage R.H. et al. [121] Wavelet features, AdaBoost, and local geometry constraints2020Classify osteoporosisJournal of Thoracic Imaging Unenhanced CT of thorax Thoracic vertebraeModerate correlation, r = 0.55 (p < 0.001)
Significant difference between normal control patients and osteoporotic group (p = 0.045)
Pickhardt P.J. et al. [101]CNN (U-Net, TernausNet)2022 Classify osteoporosis Radiology CT of abdomenL1 bone (one to seven slices)AUC = 0.860–0.930
Sensitivity: 85.4%–94.0%; Specificity: 94.6%–98.3%.
Accuracy: 89.0%–94.0%
Fang Y. et al. [95]CNN (DenseNet-121), U-Net2021Classify osteoporosisEuropean RadiologyCT of abdomen and CT of spineL1–L4 vertebraer > 0.980 (p < 0.001)
Cohen’s kappa = 0.868–0.888)
Pan Y. et al. [122]U-Net2020 Classify osteoporosisEuropean RadiologyLow-dose CT of thoraxT1–L2 vertebraer = 0.964–0.968
Mean errors: 2.2–4.0 mg/cm
AUC = 0.927 (osteoporosis), 0.942 (low BMD)
Tang C. et al. [123]CNN (MS-Net, BMDC-Net)2021Classify osteoporosis Osteoporosis InternationalCT of abdomen or lumbar spineL1 vertebraAccuracy: 76.7%
AUC = 0.917
Dzierżak, R. et al. [93]Deep CNN (VGG16, VGG19, MobileNetV2, Xception, ResNet50, and InceptionResNetV22022Classify osteoporosisSensorsCT of lumbosacral spineL1 vertebraAUC = 0.883–0.973
Accuracy: 84.0%–95.0%
Sensitivity: 78.0%–96.0%
Specificity: 86.0%–98.0%
Breit H.C. et al. [124] CNN2023Classify osteoporosisEuropean Journal of RadiologyNon-contrast CT of thoraxThoracic vertebraer = 0.51, p < 0.001 (hip BMD); r = 0.34, p = 0.01 (lumbar spine BMD)
Accuracy: 75.0%, Sensitivity: 93.0%, Specificity: 61.0%; Significantly better than clinical reports
Summers R.M. et al. [125]Computer-aided Software (QCT Pro software, versions 3.2, 4 or 4.1)2011Classify osteoporosisJournal of Computer Assisted Tomography CT, colonoscopyL1–L2 vertebraer = 0.980 (p < 0.0001)
95% limits of agreement were (−9.79, 8.46) mg/cc
Valentinitsch, A. et al. [126] RF classifier2019Classify osteoporosis Osteoporosis InternationalCT of thoracolumbar spine Thoracolumar vertebraeAUC = 0.71–0.88
Sebro R. et al. [103]Naïve Bayes; RF; SVM; XGBoost 2023Classify osteoporosis Journal of Neuroradiology CT of cervical spineC1–T1 vertebraeAUC = 0.622–0.843
Accuracy: 74.6%–99.4%
Sensitivity: 85.0%–100%
Specificity: 56.7%–98.5%
Sebro R. et al. [127](LASSO), Elastic Net, Ridge regression, and SVM with RBF 2022Prediction of osteoporosisEuropean Journal of RadiologyCT of thoraxRibs, thoracic vertebrae, sternum, and clavicler > 0.4, p < 0.001
AUC = 0.702–0.757
Liu et al. [128]LR, SVM with RBF, ANN, RF, eXtreme Gradient Boosting and Stacking 2022Classify osteoporosisBMC BioinformaticsCT images covering lumbar vertebral bodies L1–L4 vertebraeAUC = 0.818–0.962
Accuracy: 86.6%–96.0%
Sensitivity: 71.6%–96.4%
Specificity: 91.6%–96.0%
Pan J. et al. [100]ResNet-101 residual DCNN classification model 2023Classify osteoporosisResearch Square CT of thoraxL1–L2 vertebrae, L1 vertebraAUC = 0.940–0.990
Accuracy: 86.6%–94.7%
Sensitivity: 63.8%–97.6%
Specificity: 83.8%–93.0%
Lim H.K. et al. [129] Aquarius iNtuition v4.4.121, TeraRecon, Medip, RF 2021Classify osteoporosis PloS ONEUnenhanced CT of abdomen and pelvisLeft femurAUC = 0.959–0.960
Accuracy: 92.7%–92.9%; Sensitivity: 80.0%–86.6%; Specificity: 94.5%–95.8%;
Zhang K. et al. [130] CNN2023Classify osteoporosis Computational Intelligence and Neuroscience CT images covering lumbar vertebral bodiesL1–L2 vertebra AUC = 0.965–0.985
Accuracy: 93.3%–97.1%
Sensitivity: 83.6%–96.4%
Specificity: 92.2%–97.6%
Nam K.H. et al. [131]MR, LR. Tensor flow and Python2019Classify osteoporosisJournal of Korean Neurosurgical SocietyCT of lumbar spine L1–L3 vertebraAUC = 0.900
Accuracy: 92.5%
F1 score: 0.954;
Xu Y. et al. [132]SVM and kNN2013Classify osteoporosisMicroscopy Research TechniqueMicro-CT-F1 score: 0.900–0.958
Precision: 91.3%–95.3%
Löffler, M.T. et al. [98]CNN2021Classify osteoporosis European RadiologyCT of lumbar spineL1–L4AUC = 0.860–0.885
Sensitivity: 41.0%–86.0%
Specificity: 78.0%–98.0%
(superior to DXA for predicting osteoporosis in patients with vertebral fractures
Krishnaraj A. et al. [133]Machine learning-based regression 2019Classify osteoporosisJournal of American College of RadiologyCT of abdomen and pelvisL1–L4 vertebraeAccuracy: 82.0%; Sensitivity: 84.4%; Specificity: 72.7%
Chen Y.C. et al. [134] CNN (ResNet50), SVM 2023Classify osteoporosisEuropean RadiologyLow-dose CT of thoraxThoracic vertebraeAUC = 0.960–0.980
Accuracy: 85.0%–95.0%
Sensitivity: 85.0%–94.0%
Specificity: 85.0%–92.0%
Tariq A. et al. [135]CNN (Densenet121)2023Classify osteoporosisMedical PhysicsContrasted/non-contrasted CT of abdomen and pelvisL3 vertebraeAUC = 0.830 (axial), 0.830 (coronal), 0.860 (imaging + demographic factors)
Elmahdy, M. et al. [94]SVM with RBF2023Classify osteoporosisStudies in Health Technology and InformaticsCT of kneeDistal femur, proximal tibia and fibula, and patella AUC = 0.937
Sensitivity: 83.3%
Specificity: 100.0%
Sollmann N. et al. [136]CNN (DenseNet)2022Classify osteoporosisJournal of Bone Mineral ResearchCT of abdomen and pelvisT6 to L5 vertebraeAUC = 0.815–0.862
Yang J. et al. [69]CNN2022Classify osteoporosisOsteoporosis InternationalCT of thoraxThoracic vertebraeAUC = 0.831–0.972
Sensitivity: 73.8%–95.6%
Specificity: 73.6%–88.0%
Sebro R. et al. [137]SVM with RBF2022Classify osteoporosisDiagnosticsCT of wrist/forearmForearm, carpal, and metacarpal bones AUC = 0.818 (radius)
Sensitivity: 69.2%
Specificity: 77.1%
r = 0.74–0.85
Yoshida K. et al. [138]CNN (ResNet50) 2023 Classify osteoporosisJournal Computer Assisted Tomography Non-contrasted CT images covering lumbar vertebral bodiesL1–L4 vertebraeAUC = 0.921–0.969
r = 0.81
Accuracy: 73.0%–94.0%
Sensitivity: 73.0%–100%
Specificity: 73.0%–94.0%
Dai H. et al. [139]LASSO regression model2023Classify osteoporosisActa RadiologicalCT of abdomenLumbar vertebraer  =  0.932
Huang C.B. et al. [96]LASSO, GNB, RF, LR, SVM, GBM, XGBoost2022 Classify osteoporosisBMC GeriatricsCT of abdomenPsoas at L3 level AUC = 0.860
Accuracy: 81.0%
Sensitivity: 70.0%, Specificity 92.0%
Naghavi M. et al. [140]CNN (Unet)2023Classify osteoporosisJournal of the American College of RadiologyCT, coronary artery calcium scoringThoracic vertebraer = 0.84
AutoBMD averaged 15 s per report vs. 5.5 min for manual measurements (p < 0.0001).
Naghavi M. et al. [99] CNN (Unet)2023Classify osteoporosisEuropean Journal of Radiology OpenLow-dose CT of thorax, CT, coronary artery calcium scoringThoracic vertebraeR2 = 0.95 (p < 0.0001)
Similar results in both modalities
Küçükçiloğlu Y. et al. [97]CNN (InceptionV, EfficientNetV2S, ResNet502023Classify osteoporosisDiagnostic Interventional RadiologyCT of lumbar spine
MRI of lumbar spine
Lumbar vertebrae AUC = 0.942–0.988(CT)
Accuracy: 98.8% (CT)
Sensitivity: 98.5% (CT)
Specificity: 99.2% (CT)
AUC = 0.980 (CT + MRI)
Accuracy: 96.8% (CT + MRI)
Sensitivity: 96.7% (CT + MRI)
Specificity: 96.8% (CT + MRI)
Wang J. et al. [104]PyRadiomics, LASSO 2023Classify osteoporosisBMC Musculoskeletal DisorderCT of lumbar spineL1 vertebra AUC = 0.902–0.988
Accuracy: 86.0%–94.0%
Sensitivity: 85.7%–87.5%
Specificity: 80.0%–97.2%
Jiang, Y.W. et al. [105]mRMR, LASSO2022Detect osteoporosisEuropean RadiologyCT of lumbar spineL1 vertebra AUC = 0.762–0.969
Accuracy: 75.9%–87.1%
Sensitivity: 59.5%–73.0%
Specificity: 83.5%–93.7%
Xue Z. et al. [141]PyRadiomics, SVM, RF, KNN2022Detect osteoporosisBMC Musculoskeletal DisorderCT of lumbar spineL1–L4 vertebrae AUC = 0.994 (normal vs. osteoporosis)
AUC = 0.866 (osteopenia vs. osteoporosis)
AUC = 0.940 (normal vs. osteopenia)
Qiu H. et al. [142]mRMR, LASSO2022Detect osteoporosisFrontiers in EndocrinologyCT covering lumbar vertebra bodiesParavertebral muscles at the level of the L1 vertebra AUC = 0.900 (radiomics); 0.950 (radiomics + clinical features)
Accuracy: 81.4%–88.1%
Sensitivity: 85.7%–88.9%
Specificity: 77.4%–87.5%
Mookiah M.R.K. et al. [143]SVM2018Classify osteoporosisOsteoporosis International CT images covering thoracolumbar spineThoracolumbar spine Accuracy: 83.0%
Sensitivity: 93.3%
Specificity: 79.3%
r = 0.91–0.96
Area under the curve (AUC), random forest (RF), support vector machine (SVM), artificial neural network (ANN), convolutional neural network (CNN), radial basis function (RBF), logistic regression (LR), multiple regression (MR), k-nearest neighbor (kNN), least absolute shrinkage and selection operator (LASSO), Gaussian naïve Bayes (GNB), gradient boosting machine (GBM), minimum redundancy–maximum relevance (mRMR).
Table 2. Summary of Results.
Table 2. Summary of Results.
Areas SampledNo. of StudiesArea under the Curve (AUC)AccuracySensitivitySpecificityr
Cervical vertebrae10.622–0.84374.6%–99.4%85.0%–100%56.7%–98.5%0.270–0.670
Thoracic vertebrae60.831–0.98085.0%–95.0%73.8%–95.6%73.6%–92.0%0.34 0–0.510
Thoracolumbar vertebrae40.710–0.95283.0%93.0%79.3%0.910–0.968
Lumbar vertebrae210.582–0.99473.0%–98.8%41.0%–100%73.0%–99.2%0.582–0.911
Other regions70.630–0.96061.8%–92.9%61.8%–95.0%31.0%–100%0.400–0.600
Overall390.582–0.99461.8%–99.4%41.0%–100%31.0%–100%0.270–0.968

4. Discussion

4.1. Advantages and Efficacy

CT examinations performed for other indications present a unique opportunity for incidental osteoporosis screening with no additional cost, time penalty, or radiation exposure for patients [74,144,145]. Many studies have already shown that information from a single L1 vertebra body on CT correlates well not only with T-scores from DEXA [74] but also with the risk of future osteoporotic fractures [146,147,148]. The wealth of data obtained from this straightforward evaluation of trabecular attenuation values in CT scans can even compete with the predictive capabilities offered by the more cumbersome FRAX (fracture risk assessment tool) method [149,150]. The FRAX method is a widely used clinical tool that estimates the 10-year probability of fractures on the basis of various clinical risk factors and bone mineral density measurements. Despite its prevalence, the simplicity and accuracy of trabecular attenuation values from CT scans present a compelling alternative for evaluating bone health.
The utilization of CT images for osteoporosis prediction and classification has been enabled by recent advancements in AI and deep learning techniques. Deep learning methods like CNNs enhance the accuracy of osteoporosis diagnosis by constructing multi-hidden-layer models and leveraging extensive training data sets to identify, extract, and learn valuable features. These methods provide unique insights into bone quality and microstructure that cannot be attained solely through DEXA scans or visual assessment, ultimately elevating the accuracy of osteoporosis prediction and classification. Yasaka et. al. [66] revealed that a BMD model using CNN on CT images was slightly superior (AUC = 0.965–0.970) to past estimations of BMD using CT attenuation (AUC = 0.829–0.953) alone (p = 0.013). Their BMD model also showed a higher positive correlation to DEXA-based BMD estimation (r = 0.852 vs. r = 0.425 for CT attenuation alone, p < 0.001).
A crucial facet of AI technology lies in its proficiency for automated segmentation [151,152,153], which not only minimizes processing time but also improves the precision of region of interest (ROI) placement. This is especially advantageous in atypical cases in which manual segmentation is both time-consuming and challenging, leading to an enhancement in sensitivity when classifying osteoporosis in such complex scenarios. The deep learning-based BMD tool developed by Pickhardt et al. [84] demonstrated a significantly higher success rate in accurately placing and sizing regions of interest (ROIs) compared with an older automated feature-based algorithm (99.3% vs. 89.4%, p < 0.001). This difference was particularly evident among patients with suboptimal positioning, deformities like scoliosis, metallic hardware, or other structural variations that can impact BMD measurements when using DEXA.
Radiomics is a widely applied technique in clinical oncology for tasks such as cancer detection and diagnosis, forecasting outcomes and prognosis, and predicting post-treatment response [154,155,156]. Recently, several studies have emerged in which textural characteristics extracted from X-rays, MRI scans, and DEXA scans have been applied to detect, diagnose, and classify osteoporosis and other metabolic bone disorders [141,142,143,144]. However, the diagnostic accuracy for osteoporosis on these modalities remains inadequate, with reported values for the area under the curve (AUC) in osteoporosis classification typically hovering around 0.8. These limitations may be attributed to the choice of the region of interest (ROI), which often lacks a comprehensive 3D reconstruction of the entire vertebral body. As a result, this omission potentially results in the exclusion of pertinent information, thereby impacting the accuracy of the predictive model.
CT has the advantage of 3D evaluation of bone mineralization and allows for volumetric analysis of the entire vertebral body rather than the assessment of just a small sample of the vertebral body trabeculae. Volumetric measurement of BMD is known to be more sensitive and precise than DEXA for detecting bone mineral loss, as it avoids the superimposition of cortical bone and other soft tissues [157]. The model created by Xue et al. [141] achieved a high AUC of 0.994 in differentiating normal and osteoporotic bones using radiomics features extracted from volumetric analysis of the lumbar spine on CT images.
Measuring CT attenuation or the Hounsfield Units (HUs) of vertebral bodies has been extensively explored as a method for osteoporosis detection, given that it is an easily accessible tool on most PACSs [158] with the assistance of phantom and phantomless calibration. However, this approach has inherent limitations. Firstly, the calibration equation is susceptible to variations in scan protocols, phantom positioning, and, in the case of phantomless calibration, the patient cohort used [56,159]. As such, it cannot be applied retrospectively, and it may not be reproducible in other cohorts or institutions. By contrast, machine learning models incorporate the analysis of imaging features beyond CT attenuation alone and may even surpass conventional HU measurements alone. Jiang et al. [88] demonstrated the effectiveness of a CT-based radiomics signature generated through 3D feature extraction from the lumbar spine. This approach outperformed HU measurements alone, achieving an AUC of 0.960 (p < 0.05) and offering a higher overall net benefit, as determined by decision curve analysis.
AI facilitates the seamless integration of radiomics with clinical information to create a robust model for classifying BMD on the basis of CT images. Clinical data and demographic traits [160,161] have been employed to identify individuals with osteoporosis or osteoporotic fractures, playing a pivotal role in the development of various tools for osteoporosis assessment [162]. The inclusion of clinical characteristics (such as age, sex, and risk factors as per the National Osteoporosis Foundation Guidelines [145]) in BMD assessment using DEXA has previously shown promising results in predicting osteoporosis, as demonstrated by Wang et al. [104]. Their radiomics clinical model achieved an AUC of 0.988, compared with an AUC of 0.902 with radiomics alone (although this difference was not statistically significant, p = 0.643). Notably, a radiomics model that incorporates both clinical and CT imaging data has the potential to match or even surpass the performance of DEXA alone, which primarily focuses on bone density analysis. A study by Liu et al. [128] demonstrated that their logistic regression model including clinical and CT imaging data achieved superior performance with an AUC of 0.962 compared with using either clinical data alone (AUC = 0.819–0.828) or CT image features alone (AUC = 0.876–0.953). These findings emphasize the promise of AI-driven models that leverage both radiomics and clinical data for improved osteoporosis classification.
The primary objective of opportunistic osteoporosis screening via CT images is to leverage CT scans conducted for unrelated purposes to diagnose and classify osteoporosis. To date, no studies have compared the effectiveness of AI-assisted screening using CT scans for other indications against those specifically conducted for osteoporosis diagnostics, such as quantitative CT. However, we hypothesize that the latter methods may offer more accurate and detailed information, given their adherence to strict acquisition protocols [163,164]. Further studies are needed to evaluate this aspect, an important step before determining the viability of opportunistic osteoporosis screening using CT scans from diverse medical contexts. Later, this paper discusses various technical considerations for employing CT images from other indications in osteoporosis diagnosis and classification, providing valuable insights for future studies and model development.

4.1.1. Technical Considerations: Labeling and Segmentation

An important aspect of automated segmentation lies in the precise labeling of bones and vertebral levels [163]. In the majority of CT scans of the chest or abdomen, the entire spine is not fully captured, and the vertebra of interest may be at the edge of the field of view, resulting in partial inclusion. Consequently, the model’s capability should not rely on the specific number or position of the vertebrae within the scan. Instead, it should consider alternative features, such as rib count [150], for identification and segmentation. Accurate labeling of vertebral levels is important as it has been demonstrated that BMD can decrease from the thoracic to the lumbar spine [164,165]. Furthermore, the task of correct vertebral labeling can be further complicated by the presence of transitional vertebrae [32,153]. Developing a robust AI model that includes such complex cases within its training set may offer a potential solution to this challenge.

4.1.2. Technical Considerations: Contrast versus Non-Contrast

The majority of clinical CT scans employ contrast agents to examine structures such as blood vessels, soft tissues, and other internal body organs for various medical conditions. However, the use of contrast alters the way tissues absorb X-rays, resulting in an approximate 8–10% increase in the CT attenuation of trabecular bone [154] compared with unenhanced scans [155,156]. Notably, the impact of contrast on bone trabeculation varies depending on the region of interest sampled, primarily due to differences in blood supply and vasculature. Bauer et al. [166] demonstrated that contrast enhancement increased synchronous phantom-derived BMD values by approximately 31% in the lumbar spine and 2% in the proximal femur compared with unenhanced CT scans.
Several studies have explored the use of internal calibration to address differences between contrasted and non-contrast studies, but these efforts have encountered limited success [158,159]. Key challenges have been identified, including the heterogeneity in marrow enhancement caused by multiple factors, such as the time elapsed between contrast administration and CT scan acquisition, heterogeneity in marrow enhancement due to differences in bone mineral density, and other contributing factors [160]. With the emergence of AI and machine learning, models can now be trained to incorporate both enhanced and unenhanced CT scans, enabling them to adapt their prediction algorithms. This adaptation may involve adjusting CT attenuation thresholds for patients with contrast-enhanced CT studies [112] or even identifying the contrast phase to correct for variations [73,161]. This approach could overcome the need for a one-size-fits-all internal calibration, making it applicable to a wider range of datasets.

4.1.3. Technical Considerations: Areas Sampled

The location and types of bones selected for sampling are recognized to give varying BMD results, a phenomenon also observed in DEXA studies [167]. In our study, we found that investigations focusing on the thoracolumbar or lumbar spine (Table 2) generally exhibited stronger positive correlations, reaching up to r = 0.968 and r = 0.911, respectively, in comparison with examinations of other anatomical regions (such as cervical vertebrae, with r = 0.670; thoracic vertebrae, with r = 0.510; and other body parts, with r = 0.600) in relation to BMD results acquired via DEXA. This trend is likely due to the proximity of the thoracolumbar and lumbar vertebrae to the areas typically sampled by DEXA (usually the L1–L4 vertebrae) for BMD classification and osteoporosis assessment. Even though variations in BMD exist across different bones, meaningful comparisons remain feasible between various skeletal sites due to the strong correlations established between them [163,164,165,166].
Evaluating non-spinal skeletal sites on CT for osteoporosis represents a valuable clinical approach to assessing bone health beyond traditional spine assessment. Analyzing peripheral sites, such as the hip or wrist, could provide clinicians with a comprehensive understanding of a patient’s overall skeletal integrity [168,169]. Furthermore, non-spinal skeletal sites may be subjected to fewer degenerative changes [170], enhancing their predictive value for BMD and future fracture risk. The sites evaluated in the literature include the hip, distal femur [129], tibial, fibula [94], distal radius, hand bones [137], ribs, sternum, and clavicle [127]. This broader assessment can be particularly useful in cases in which spine imaging is not performed or when it will not provide a complete picture of the patient’s bone health, e.g., vertebral degeneration, fractures, or instrumentation precludes accurate assessment. Additionally, scanning these sites exposes essential organs to less radiation.
Detailed information about localized bone health at these peripheral sites can prove important in guiding treatment decisions. For instance, Gruenewald et al. [34] demonstrated the opportunistic evaluation of BMD during planning CT scans for distal radius fracture fixation. This approach helped predict outcomes and the need for surgical bone substitutes during fixation, especially for patients with a mean volumetric BMD lower than 79.6 mg/cm3 who required surgical bone substitutes during fixation, as well as patients with a mean volumetric BMD lower than 71.1 mg/cm3 who developed bone non-union (AUC = 0.710–0.910). This promising approach may extend to other common fracture sites such as the femoral neck, helping predict the need for surgical treatment and guiding interventions to enhance patient outcomes.
Interestingly, two studies by Huang CB et al. [79] and Qiu H. et al. [127] adopted a unique approach by sampling muscles rather than the bony skeleton to predict and classify osteoporosis. This strategy capitalizes on the established link between sarcopenia and osteoporosis [167,168,169]. Prior studies have shown that individuals with both sarcopenia and low BMD have an increased risk of insufficiency fractures [129,170]. The radiomics model developed by Huang CB et al., which employed gradient boosting methods (GBMs), achieved an AUC of up to 0.860 and an accuracy of 81.0% on validation sets [79]. This method of classifying osteoporosis is especially useful in cases in which direct sampling of the vertebral body may not provide an accurate representation of bone density, for example, in cases of severe spinal spondylosis [171].
The accuracy of a machine learning model utilizing CT attenuation values from multiple bones in conjunction with clinical and demographic variables exceeded that of models relying on a single bone. Uemura K. et al. [120] demonstrated that their model, when limited to sampling just the L1 vertebral region, achieved an AUC of 0.582, significantly lower than when they expanded their sampling to include the L1–L4 vertebrae (AUC = 0.941). Similarly, Sebro R et al. [137] showed that using data from multiple bones in the wrist yielded superior accuracy in contrast to relying on CT attenuation values from a single bone. These observations suggest that future comparative studies should be performed across various skeletal areas to determine the optimal region(s) and the extent of sampling for enhanced accuracy.

4.2. Other Potential Applications: Incorporating Molecular and Genetic Biomarkers

Recent advances in molecular diagnostics have shown remarkable potential in the realm of bone mineral density (BMD) and osteoporosis diagnosis [172,173]. In particular, testing for bone turnover markers (BTMs) detects peptides produced during bone matrix formation and degradation [174,175]. These are substances found in the blood and urine, providing information about the rate at which bone tissue is broken down (resorption) and formed (formation). Notably, BTMs such as PINP (N-terminal propeptide of type I procollagen) and CTX (C-telopeptide of type I collagen) [176] can offer early detection of bone loss before it becomes severe, which is particularly valuable in identifying individuals who may benefit from preventive measures and early intervention. This is possible because BTMs reflect the dynamic process of bone remodeling, thereby providing real-time information about bone health before changes can be detected by conventional DEXA scans [177,178]. However, these molecular tests and genetic analyses can be costly and may require specialized laboratories [179,180]. Furthermore, they are subject to significant pre-analytical and analytical variability, with a lack of standardization for BTM assays [181].
AI has the potential to assist in the molecular diagnosis and genetic analysis of osteoporosis when applied to CT scans. While relatively new in the field of bone health, the use of AI to analyze imaging features to determine genomic signatures and advanced biomarkers has been extensively studied in the realm of oncology, known as radiogenomics [182,183]. For instance, Ren et al. [184] and Fan et al. [185] were able to predict EGFR mutation status using radiomics analysis on vertebral metastases from lung cancer, eliminating the need for actual testing. Xu R. et al. [186] were able to develop a radiomics model to predict molecular biomarkers such as estrogen receptors (ERs), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2) status using ultrasound images of the breast, which otherwise can only be obtained by biopsy or surgery. Similarly, AI models could be trained to predict molecular markers (such as BTMs) and genetic markers from CT images without the need for formal testing. The combination of AI with CT diagnostic methods and molecular-level assessments has the potential to enhance our understanding of osteoporosis, improve early detection, enable personalized treatment strategies, and ultimately reduce the burden of this disease on individuals and healthcare systems.

4.3. Challenges in Implementation

Despite achieving numerous promising outcomes, the integration of various AI methods for CT screening of osteoporosis into clinical practice faces several challenges that need addressing. Firstly, AI development requires a substantial volume of medical imaging data, raising concerns about data ownership, usage for research, informed consent, and patient confidentiality, often contingent on local legal frameworks [187]. In addition, the training and validation of medical image algorithms involve a time-intensive and costly process of labeling numerous parameters, typically performed by radiologists [188]. Relying on smaller datasets from a single institution can yield unreliable results when applying the AI model to a different population, posing challenges related to generalizability and reproducibility [189,190]. To mitigate these issues, external validation and the use of large multicentre databases as benchmarks are necessary to enhance AI model performance before clinical implementation [191,192,193]. However, coordinating such extensive projects can be challenging.
Additionally, the seamless integration of AI models into the clinical workflow and interface with existing radiology information systems (RISs) and picture archiving and communication systems (PACS) is crucial [194]. This integration can be problematic, especially due to variations in IT environments across different institutions [195] and the absence of standardized protocols for data sharing between digital systems [196].

5. Conclusions

This systematic review highlights the growing body of evidence that underscores the promise of harnessing artificial intelligence in tandem with CT scans for osteoporosis screening and classification. The synergy between advanced imaging technologies and AI algorithms presents an opportunity to revolutionize osteoporosis diagnosis and risk assessment. Our study highlights various key considerations for the use of CT imaging as an opportunistic screening tool for osteoporosis, facilitated by AI assistance. These insights may be helpful for forthcoming research, spanning model development through to clinical integration.
Most of the research conducted in this field has consisted of preliminary investigations, retrospective analyses, or studies conducted at single centers, often with small sample sizes. Consequently, the models developed in these studies have limited applicability, and when applied to external datasets, they often yield variable results due to significant heterogeneity. This variability hampers the ability to reproduce results consistently and hinders the development of AI models suitable for clinical implementation. To address this issue, additional research, particularly randomized controlled trials or large-scale multi-center studies, is essential to validate these applications and pave the way for their seamless integration into standard clinical practice.
This study also discussed the significance of technical considerations when analyzing CT images for opportunistic osteoporosis diagnosis in non-osteoporosis contexts, offering valuable insights for future model development. Furthermore, the incorporation of clinical characteristics and radiomics features in AI-based osteoporosis diagnosis may outperform conventional methods across diverse clinical settings. While this shows promise, further research should address clinical and implementation aspects before clinical translation is feasible.
Finally, our article offers a comprehensive review of the available evidence regarding the use of CT images for classifying osteoporosis. However, it is important to acknowledge the inherent limitations of a scoping review, such as the absence of detailed data extraction, the omission of statistical analysis, and the lack of a formal quality assessment for the included studies, which may have introduced subjectivity and potential bias into our findings. Nevertheless, our review article should serve as a valuable resource for future research projects in this field.

Author Contributions

Conceptualization, methodology, supervision, and writing: W.O., R.W.L., A.M., J.H.T., N.K. and J.T.P.D.H. Investigation and project administration: W.O., R.W.L. and J.T.P.D.H. Resources and software: W.O., R.W.L., A.M., X.Z.L., W.J.S. and J.T.P.D.H. Formal analysis and validation: W.O., R.W.L. and J.T.P.D.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by (1) direct funding from MOH/NMRC: this research was supported by the Singapore Ministry of Health National Medical Research Council under the NMRC Clinician Innovator Award (CIA), grant title: Deep learning pipeline for augmented reporting of MRI whole spine (CIAINV23jan-0001, MOH-001405).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ensrud, K.E.; Crandall, C.J. Osteoporosis. Ann. Intern. Med. 2017, 167, itc17–itc32. [Google Scholar] [CrossRef]
  2. Salari, N.; Ghasemi, H.; Mohammadi, L.; Behzadi, M.h.; Rabieenia, E.; Shohaimi, S.; Mohammadi, M. The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. J. Orthop. Surg. Res. 2021, 16, 609. [Google Scholar] [CrossRef]
  3. Xiao, P.L.; Cui, A.Y.; Hsu, C.J.; Peng, R.; Jiang, N.; Xu, X.H.; Ma, Y.G.; Liu, D.; Lu, H.D. Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: A systematic review and meta-analysis. Osteoporos. Int. 2022, 33, 2137–2153. [Google Scholar] [CrossRef] [PubMed]
  4. Center, J.R.; Nguyen, T.V.; Schneider, D.; Sambrook, P.N.; Eisman, J.A. Mortality after all major types of osteoporotic fracture in men and women: An observational study. Lancet 1999, 353, 878–882. [Google Scholar] [CrossRef] [PubMed]
  5. Cooper, C.; Atkinson, E.J.; Jacobsen, S.J.; O’Fallon, W.M.; Melton, L.J., 3rd. Population-based study of survival after osteoporotic fractures. Am. J. Epidemiol. 1993, 137, 1001–1005. [Google Scholar] [CrossRef] [PubMed]
  6. Melton, L.J., 3rd. Adverse outcomes of osteoporotic fractures in the general population. J. Bone Miner. Res. 2003, 18, 1139–1141. [Google Scholar] [CrossRef] [PubMed]
  7. D’Elia, R.; Iannazzo, S.; Rossigni, A.; Santi, A.L.; Patti, A.M. Osteoporosis: Problems and considerations of economical nature. Ann. Ig. 2004, 16, 59–67. [Google Scholar]
  8. Dunnewind, T.; Dvortsin, E.P.; Smeets, H.M.; Konijn, R.M.; Bos, J.H.J.; de Boer, P.T.; van den Bergh, J.P.; Postma, M.J. Economic Consequences and Potentially Preventable Costs Related to Osteoporosis in the Netherlands. Value Health 2017, 20, 762–768. [Google Scholar] [CrossRef]
  9. Kelly, R.R.; McDonald, L.T.; Jensen, N.R.; Sidles, S.J.; LaRue, A.C. Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions. Front. Psychiatry 2019, 10, 200. [Google Scholar] [CrossRef]
  10. Gold, D.T. The nonskeletal consequences of osteoporotic fractures. Psychologic and social outcomes. Rheum. Dis. Clin. N. Am. 2001, 27, 255–262. [Google Scholar] [CrossRef]
  11. Gold, T.; Williams, S.A.; Weiss, R.J.; Wang, Y.; Watkins, C.; Carroll, J.; Middleton, C.; Silverman, S. Impact of fractures on quality of life in patients with osteoporosis: A US cross-sectional survey. J. Drug Assess. 2019, 8, 175–183. [Google Scholar] [CrossRef]
  12. Singer, A.; McClung, M.R.; Tran, O.; Morrow, C.D.; Goldstein, S.; Kagan, R.; McDermott, M.; Yehoshua, A. Treatment rates and healthcare costs of patients with fragility fracture by site of care: A real-world data analysis. Arch. Osteoporos. 2023, 18, 42. [Google Scholar] [CrossRef]
  13. Williams, S.A.; Chastek, B.; Sundquist, K.; Barrera-Sierra, S.; Leader, D., Jr.; Weiss, R.J.; Wang, Y.; Curtis, J.R. Economic burden of osteoporotic fractures in US managed care enrollees. Am. J. Manag. Care 2020, 26, e142–e149. [Google Scholar] [CrossRef] [PubMed]
  14. Carter, M.I.; Hinton, P.S. Physical activity and bone health. Mo. Med. 2014, 111, 59–64. [Google Scholar] [PubMed]
  15. Stanghelle, B.; Bentzen, H.; Giangregorio, L.; Pripp, A.H.; Bergland, A. Associations between health-related quality of life, physical function and pain in older women with osteoporosis and vertebral fracture. BMC Geriatr. 2019, 19, 298. [Google Scholar] [CrossRef]
  16. Cooper, C.; Campion, G.; Melton, L.J., 3rd. Hip fractures in the elderly: A world-wide projection. Osteoporos. Int. 1992, 2, 285–289. [Google Scholar] [CrossRef]
  17. Porter, J.L.; Varacallo, M. Osteoporosis; StatPearls: Treasure Island, FL, USA, 2023. [Google Scholar]
  18. Tucci, J.R. Importance of early diagnosis and treatment of osteoporosis to prevent fractures. Am. J. Manag. Care 2006, 12, S181–S190. [Google Scholar]
  19. Tothill, P.; Laskey, M.A.; Orphanidou, C.I.; van Wijk, M. Anomalies in dual energy X-ray absorptiometry measurements of total-body bone mineral during weight change using Lunar, Hologic and Norland instruments. Br. J. Radiol. 1999, 72, 661–669. [Google Scholar] [CrossRef] [PubMed]
  20. World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis: Report of a WHO Study Group; meeting held in Rome from 22 to 25 June 1992; World Health Organization: Geneva, Switzerland, 1994. [Google Scholar]
  21. Kanis, J.A.; Melton, L.J., 3rd; Christiansen, C.; Johnston, C.C.; Khaltaev, N. The diagnosis of osteoporosis. J. Bone Miner. Res. 1994, 9, 1137–1141. [Google Scholar] [CrossRef]
  22. Sheu, A.; Diamond, T. Bone mineral density: Testing for osteoporosis. Aust. Prescr. 2016, 39, 35–39. [Google Scholar] [CrossRef]
  23. Varacallo, M.; Seaman, T.J.; Jandu, J.S.; Pizzutillo, P. Osteopenia; StatPearls Publishing LLC.: Treasure Island, FL, USA, 2023. [Google Scholar]
  24. Kanis, J. Assessment of Osteoporosis at the Primary Health-Care Level. Technical Report. 2008. Available online: http://www.shef.ac.uk/FRAX (accessed on 21 August 2023).
  25. Adams, J.E. Quantitative computed tomography. Eur. J. Radiol. 2009, 71, 415–424. [Google Scholar] [CrossRef]
  26. Cummings, S.R.; Bates, D.; Black, D.M. Clinical use of bone densitometry: Scientific review. JAMA 2002, 288, 1889–1897. [Google Scholar] [CrossRef] [PubMed]
  27. Nayak, S.; Roberts, M.S.; Greenspan, S.L. Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women. Ann. Intern. Med. 2011, 155, 751–761. [Google Scholar] [CrossRef] [PubMed]
  28. Kling, J.M.; Clarke, B.L.; Sandhu, N.P. Osteoporosis prevention, screening, and treatment: A review. J. Womens Health 2014, 23, 563–572. [Google Scholar] [CrossRef] [PubMed]
  29. Ito, K. Cost-effectiveness of Screening for Osteoporosis in Older Men With a History of Falls. JAMA Netw. Open 2020, 3, e2027584. [Google Scholar] [CrossRef] [PubMed]
  30. Small, R.E. Uses and limitations of bone mineral density measurements in the management of osteoporosis. Medscape Gen. Med. 2005, 7, 3. [Google Scholar]
  31. Miller, P.D.; Zapalowski, C.; Kulak, C.A.; Bilezikian, J.P. Bone densitometry: The best way to detect osteoporosis and to monitor therapy. J. Clin. Endocrinol. Metab. 1999, 84, 1867–1871. [Google Scholar] [CrossRef]
  32. Curtis, J.R.; Carbone, L.; Cheng, H.; Hayes, B.; Laster, A.; Matthews, R.; Saag, K.G.; Sepanski, R.; Tanner, S.B.; Delzell, E. Longitudinal trends in use of bone mass measurement among older americans, 1999–2005. J. Bone Min. Res. 2008, 23, 1061–1067. [Google Scholar] [CrossRef]
  33. Gillespie, C.W.; Morin, P.E. Trends and Disparities in Osteoporosis Screening Among Women in the United States, 2008–2014. Am. J. Med. 2017, 130, 306–316. [Google Scholar] [CrossRef]
  34. Siris, E.S.; Chen, Y.T.; Abbott, T.A.; Barrett-Connor, E.; Miller, P.D.; Wehren, L.E.; Berger, M.L. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch. Intern. Med. 2004, 164, 1108–1112. [Google Scholar] [CrossRef]
  35. Williams, S.; Khan, L.; Licata, A.A. DXA and clinical challenges of fracture risk assessment in primary care. Clevel. Clin. J. Med. 2021, 88, 615–622. [Google Scholar] [CrossRef] [PubMed]
  36. Tenne, M.; McGuigan, F.; Besjakov, J.; Gerdhem, P.; Åkesson, K. Degenerative changes at the lumbar spine--implications for bone mineral density measurement in elderly women. Osteoporos. Int. 2013, 24, 1419–1428. [Google Scholar] [CrossRef]
  37. Grams, A.E.; Rehwald, R.; Bartsch, A.; Honold, S.; Freyschlag, C.F.; Knoflach, M.; Gizewski, E.R.; Glodny, B. Correlation between degenerative spine disease and bone marrow density: A retrospective investigation. BMC Med. Imaging 2016, 16, 17. [Google Scholar] [CrossRef]
  38. Chirvi, S.; Pintar, F.A.; Yoganandan, N.; Stemper, B.; Kleinberger, M. Trabecular bone mineral density correlations using QCT: Central and peripheral human skeleton. J. Mech. Behav. Biomed. Mater. 2020, 112, 104076. [Google Scholar] [CrossRef]
  39. Jørgensen, H.S.; Borghs, H.; Heye, S.; Smout, D.; Claes, K.; Evenepoel, P. Vascular calcification of the abdominal aorta has minimal impact on lumbar spine bone density in patients with chronic kidney disease. Bone 2022, 162, 116482. [Google Scholar] [CrossRef]
  40. Spencer, R.P.; Szigeti, D.P.; Engin, I.O. Effect of Laminectomy on Measured Bone Density. J. Clin. Densitom. 1998, 1, 375–377. [Google Scholar] [CrossRef]
  41. Jacobson, J.A.; Jamadar, D.A.; Hayes, C.W. Dual X-ray absorptiometry: Recognizing image artifacts and pathology. Am. J. Roentgenol. 2000, 174, 1699–1705. [Google Scholar] [CrossRef]
  42. Garg, M.K.; Kharb, S. Dual energy X-ray absorptiometry: Pitfalls in measurement and interpretation of bone mineral density. Indian. J. Endocrinol. Metab. 2013, 17, 203–210. [Google Scholar] [CrossRef]
  43. Vetter, J.R.; Perman, W.H.; Kalender, W.A.; Mazess, R.B.; Holden, J.E. Evaluation of a prototype dual-energy computed tomographic apparatus. II. Determination of vertebral bone mineral content. Med. Phys. 1986, 13, 340–343. [Google Scholar] [CrossRef] [PubMed]
  44. van Hamersvelt, R.W.; Schilham, A.M.R.; Engelke, K.; den Harder, A.M.; de Keizer, B.; Verhaar, H.J.; Leiner, T.; de Jong, P.A.; Willemink, M.J. Accuracy of bone mineral density quantification using dual-layer spectral detector CT: A phantom study. Eur. Radiol. 2017, 27, 4351–4359. [Google Scholar] [CrossRef] [PubMed]
  45. Booz, C.; Noeske, J.; Albrecht, M.H.; Lenga, L.; Martin, S.S.; Yel, I.; Huizinga, N.A.; Vogl, T.J.; Wichmann, J.L. Diagnostic accuracy of quantitative dual-energy CT-based bone mineral density assessment in comparison to Hounsfield unit measurements using dual x-ray absorptiometry as standard of reference. Eur. J. Radiol. 2020, 132, 109321. [Google Scholar] [CrossRef]
  46. Li, N.; Li, X.-M.; Xu, L.; Sun, W.-J.; Cheng, X.-G.; Tian, W. Comparison of QCT and DXA: Osteoporosis Detection Rates in Postmenopausal Women. Int. J. Endocrinol. 2013, 2013, 895474. [Google Scholar] [CrossRef]
  47. Alawi, M.; Begum, A.; Harraz, M.; Alawi, H.; Bamagos, S.; Yaghmour, A.; Hafiz, L. Dual-Energy X-Ray Absorptiometry (DEXA) Scan Versus Computed Tomography for Bone Density Assessment. Cureus 2021, 13, e13261. [Google Scholar] [CrossRef]
  48. Choi, K.Y.; Lee, S.-W.; In, Y.; Kim, M.S.; Kim, Y.D.; Lee, S.-y.; Lee, J.-W.; Koh, I.J. Dual-Energy CT-Based Bone Mineral Density Has Practical Value for Osteoporosis Screening around the Knee. Medicina 2022, 58, 1085. [Google Scholar] [CrossRef]
  49. Gruenewald, L.D.; Koch, V.; Martin, S.S.; Yel, I.; Eichler, K.; Gruber-Rouh, T.; Lenga, L.; Wichmann, J.L.; Alizadeh, L.S.; Albrecht, M.H.; et al. Diagnostic accuracy of quantitative dual-energy CT-based volumetric bone mineral density assessment for the prediction of osteoporosis-associated fractures. Eur. Radiol. 2022, 32, 3076–3084. [Google Scholar] [CrossRef]
  50. Nickoloff, E.L.; Feldman, F.; Atherton, J.V. Bone mineral assessment: New dual-energy CT approach. Radiology 1988, 168, 223–228. [Google Scholar] [CrossRef]
  51. de Bakker, C.M.J.; Knowles, N.K.; Walker, R.E.A.; Manske, S.L.; Boyd, S.K. Independent changes in bone mineralized and marrow soft tissues following acute knee injury require dual-energy or high-resolution computed tomography for accurate assessment of bone mineral density and stiffness. J. Mech. Behav. Biomed. Mater. 2022, 127, 105091. [Google Scholar] [CrossRef]
  52. Roski, F.; Hammel, J.; Mei, K.; Baum, T.; Kirschke, J.S.; Laugerette, A.; Kopp, F.K.; Bodden, J.; Pfeiffer, D.; Pfeiffer, F.; et al. Bone mineral density measurements derived from dual-layer spectral CT enable opportunistic screening for osteoporosis. Eur. Radiol. 2019, 29, 6355–6363. [Google Scholar] [CrossRef]
  53. Damilakis, J.; Adams, J.E.; Guglielmi, G.; Link, T.M. Radiation exposure in X-ray-based imaging techniques used in osteoporosis. Eur. Radiol. 2010, 20, 2707–2714. [Google Scholar] [CrossRef]
  54. Zhou, S.; Zhu, L.; You, T.; Li, P.; Shen, H.; He, Y.; Gao, H.; Yan, L.; He, Z.; Guo, Y.; et al. In vivo quantification of bone mineral density of lumbar vertebrae using fast kVp switching dual-energy CT: Correlation with quantitative computed tomography. Quant. Imaging Med. Surg. 2020, 11, 341–350. [Google Scholar] [CrossRef]
  55. Ghasemi Shayan, R.; Oladghaffari, M.; Sajjadian, F.; Fazel Ghaziyani, M. Image Quality and Dose Comparison of Single-Energy CT (SECT) and Dual-Energy CT (DECT). Radiol. Res. Pract. 2020, 2020, 1403957. [Google Scholar] [CrossRef]
  56. Brown, J.K.; Timm, W.; Bodeen, G.; Chason, A.; Perry, M.; Vernacchia, F.; DeJournett, R. Asynchronously Calibrated Quantitative Bone Densitometry. J. Clin. Densitom. 2017, 20, 216–225. [Google Scholar] [CrossRef]
  57. Fischer, M.; Kempers, B. Phantom studies in osteoporosis. Eur. J. Nucl. Med. 1993, 20, 434–439. [Google Scholar] [CrossRef]
  58. Koch, V.; Hokamp, N.G.; Albrecht, M.H.; Gruenewald, L.D.; Yel, I.; Borggrefe, J.; Wesarg, S.; Eichler, K.; Burck, I.; Gruber-Rouh, T.; et al. Accuracy and precision of volumetric bone mineral density assessment using dual-source dual-energy versus quantitative CT: A phantom study. Eur. Radiol. Exp. 2021, 5, 43. [Google Scholar] [CrossRef]
  59. Mussmann, B.; Andersen, P.E.; Torfing, T.; Overgaard, S. Bone density measurements adjacent to acetabular cups in total hip arthroplasty using dual-energy CT: An in vivo reliability and agreement study. Acta Radiol. Open 2018, 7, 2058460118796539. [Google Scholar] [CrossRef]
  60. Engelke, K.; Adams, J.E.; Armbrecht, G.; Augat, P.; Bogado, C.E.; Bouxsein, M.L.; Felsenberg, D.; Ito, M.; Prevrhal, S.; Hans, D.B.; et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: The 2007 ISCD Official Positions. J. Clin. Densitom. 2008, 11, 123–162. [Google Scholar] [CrossRef]
  61. Kang, J.W.; Park, C.; Lee, D.E.; Yoo, J.H.; Kim, M. Prediction of bone mineral density in CT using deep learning with explainability. Front. Physiol. 2022, 13, 1061911. [Google Scholar] [CrossRef]
  62. Issever, A.S.; Link, T.M.; Kentenich, M.; Rogalla, P.; Schwieger, K.; Huber, M.B.; Burghardt, A.J.; Majumdar, S.; Diederichs, G. Trabecular bone structure analysis in the osteoporotic spine using a clinical in vivo setup for 64-slice MDCT imaging: Comparison to microCT imaging and microFE modeling. J. Bone Miner. Res. 2009, 24, 1628–1637. [Google Scholar] [CrossRef]
  63. Schreiber, J.J.; Anderson, P.A.; Rosas, H.G.; Buchholz, A.L.; Au, A.G. Hounsfield units for assessing bone mineral density and strength: A tool for osteoporosis management. J. Bone Jt. Surg. Am. 2011, 93, 1057–1063. [Google Scholar] [CrossRef]
  64. Park, S.H.; Jeong, Y.M.; Lee, H.Y.; Kim, E.Y.; Kim, J.H.; Park, H.K.; Ahn, H.K. Opportunistic use of chest CT for screening osteoporosis and predicting the risk of incidental fracture in breast cancer patients: A retrospective longitudinal study. PLoS ONE 2020, 15, e0240084. [Google Scholar] [CrossRef]
  65. Pickhardt, P.J.; Lee, S.J.; Liu, J.; Yao, J.; Lay, N.; Graffy, P.M.; Summers, R.M. Population-based opportunistic osteoporosis screening: Validation of a fully automated CT tool for assessing longitudinal BMD changes. Br. J. Radiol. 2019, 92, 20180726. [Google Scholar] [CrossRef]
  66. Yasaka, K.; Akai, H.; Kunimatsu, A.; Kiryu, S.; Abe, O. Prediction of bone mineral density from computed tomography: Application of deep learning with a convolutional neural network. Eur. Radiol. 2020, 30, 3549–3557. [Google Scholar] [CrossRef]
  67. Vadera, S.; Osborne, T.; Shah, V.; Stephenson, J.A. Opportunistic screening for osteoporosis by abdominal CT in a British population. Insights Into Imaging 2023, 14, 57. [Google Scholar] [CrossRef]
  68. Lenchik, L.; Weaver, A.A.; Ward, R.J.; Boone, J.M.; Boutin, R.D. Opportunistic Screening for Osteoporosis Using Computed Tomography: State of the Art and Argument for Paradigm Shift. Curr. Rheumatol. Rep. 2018, 20, 74. [Google Scholar] [CrossRef]
  69. Yang, J.; Liao, M.; Wang, Y.; Chen, L.; He, L.; Ji, Y.; Xiao, Y.; Lu, Y.; Fan, W.; Nie, Z.; et al. Opportunistic osteoporosis screening using chest CT with artificial intelligence. Osteoporos. Int. 2022, 33, 2547–2561. [Google Scholar] [CrossRef]
  70. Cheng, X.; Zhao, K.; Zha, X.; Du, X.; Li, Y.; Chen, S.; Wu, Y.; Li, S.; Lu, Y.; Zhang, Y.; et al. Opportunistic Screening Using Low-Dose CT and the Prevalence of Osteoporosis in China: A Nationwide, Multicenter Study. J. Bone Miner. Res. 2021, 36, 427–435. [Google Scholar] [CrossRef]
  71. Pickhardt, P.J.; Correale, L.; Hassan, C. AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: Cost-effectiveness analysis. Abdom. Radiol. 2023, 48, 1181–1198. [Google Scholar] [CrossRef]
  72. Pickhardt, P.J. Value-added Opportunistic CT Screening: State of the Art. Radiology 2022, 303, 241–254. [Google Scholar] [CrossRef]
  73. Gausden, E.B.; Nwachukwu, B.U.; Schreiber, J.J.; Lorich, D.G.; Lane, J.M. Opportunistic Use of CT Imaging for Osteoporosis Screening and Bone Density Assessment: A Qualitative Systematic Review. J. Bone Jt. Surg. 2017, 99, 1580–1590. [Google Scholar] [CrossRef]
  74. Pickhardt, P.J.; Pooler, B.D.; Lauder, T.; del Rio, A.M.; Bruce, R.J.; Binkley, N. Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications. Ann. Intern. Med. 2013, 158, 588–595. [Google Scholar] [CrossRef]
  75. Emohare, O.; Cagan, A.; Morgan, R.; Davis, R.; Asis, M.; Switzer, J.; Polly, D.W., Jr. The use of computed tomography attenuation to evaluate osteoporosis following acute fractures of the thoracic and lumbar vertebra. Geriatr. Orthop. Surg. Rehabil. 2014, 5, 50–55. [Google Scholar] [CrossRef] [PubMed]
  76. Smith, A.D. Screening of Bone Density at CT: An Overlooked Opportunity. Radiology 2019, 291, 368–369. [Google Scholar] [CrossRef]
  77. Zhu, Y.; Triphuridet, N.; Yip, R.; Becker, B.J.; Wang, Y.; Yankelevitz, D.F.; Henschke, C.I. Opportunistic CT screening of osteoporosis on thoracic and lumbar spine: A meta-analysis. Clin. Imaging 2021, 80, 382–390. [Google Scholar] [CrossRef]
  78. Jang, S.; Graffy, P.M.; Ziemlewicz, T.J.; Lee, S.J.; Summers, R.M.; Pickhardt, P.J. Opportunistic Osteoporosis Screening at Routine Abdominal and Thoracic CT: Normative L1 Trabecular Attenuation Values in More than 20,000 Adults. Radiology 2019, 291, 360–367. [Google Scholar] [CrossRef] [PubMed]
  79. Bott, K.N.; Matheson, B.E.; Smith, A.C.J.; Tse, J.J.; Boyd, S.K.; Manske, S.L. Addressing Challenges of Opportunistic Computed Tomography Bone Mineral Density Analysis. Diagnostics 2023, 13, 2572. [Google Scholar] [CrossRef]
  80. Besler, B.A.; Michalski, A.S.; Kuczynski, M.T.; Abid, A.; Forkert, N.D.; Boyd, S.K. Bone and joint enhancement filtering: Application to proximal femur segmentation from uncalibrated computed tomography datasets. Med. Image Anal. 2021, 67, 101887. [Google Scholar] [CrossRef]
  81. Yushkevich, P.A.; Piven, J.; Hazlett, H.C.; Smith, R.G.; Ho, S.; Gee, J.C.; Gerig, G. User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability. Neuroimage 2006, 31, 1116–1128. [Google Scholar] [CrossRef]
  82. Gan, H.-S.; Ramlee, M.H.; Wahab, A.A.; Lee, Y.-S.; Shimizu, A. From classical to deep learning: Review on cartilage and bone segmentation techniques in knee osteoarthritis research. Artif. Intell. Rev. 2021, 54, 2445–2494. [Google Scholar] [CrossRef]
  83. Fasihi, L.; Tartibian, B.; Eslami, R.; Fasihi, H. Artificial intelligence used to diagnose osteoporosis from risk factors in clinical data and proposing sports protocols. Sci. Rep. 2022, 12, 18330. [Google Scholar] [CrossRef]
  84. Kim, S.K.; Yoo, T.K.; Oh, E.; Kim, D.W. Osteoporosis risk prediction using machine learning and conventional methods. In Proceedings of the 2013 35th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Osaka, Japan, 3–7 July 2013; pp. 188–191. [Google Scholar] [CrossRef]
  85. Yoo, T.K.; Kim, S.K.; Kim, D.W.; Choi, J.Y.; Lee, W.H.; Oh, E.; Park, E.C. Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning. Yonsei Med. J. 2013, 54, 1321–1330. [Google Scholar] [CrossRef]
  86. Dimai, H.P. New Horizons: Artificial Intelligence Tools for Managing Osteoporosis. J. Clin. Endocrinol. Metab. 2023, 108, 775–783. [Google Scholar] [CrossRef]
  87. Ferizi, U.; Honig, S.; Chang, G. Artificial intelligence, osteoporosis and fragility fractures. Curr. Opin. Rheumatol. 2019, 31, 368–375. [Google Scholar] [CrossRef]
  88. Hsieh, C.-I.; Zheng, K.; Lin, C.; Mei, L.; Lu, L.; Li, W.; Chen, F.-P.; Wang, Y.; Zhou, X.; Wang, F.; et al. Automated bone mineral density prediction and fracture risk assessment using plain radiographs via deep learning. Nat. Commun. 2021, 12, 5472. [Google Scholar] [CrossRef]
  89. Lis-Studniarska, D.; Lipnicka, M.; Studniarski, M.; Irzmański, R. Applications of Artificial Intelligence Methods for the Prediction of Osteoporotic Fractures. Life 2023, 13, 1738. [Google Scholar] [CrossRef]
  90. Rühling, S.; Navarro, F.; Sekuboyina, A.; El Husseini, M.; Baum, T.; Menze, B.; Braren, R.; Zimmer, C.; Kirschke, J.S. Automated detection of the contrast phase in MDCT by an artificial neural network improves the accuracy of opportunistic bone mineral density measurements. Eur. Radiol. 2022, 32, 1465–1474. [Google Scholar] [CrossRef]
  91. Sekuboyina, A.; Husseini, M.E.; Bayat, A.; Löffler, M.; Liebl, H.; Li, H.; Tetteh, G.; Kukačka, J.; Payer, C.; Štern, D.; et al. VerSe: A Vertebrae labelling and segmentation benchmark for multi-detector CT images. Med. Image Anal. 2021, 73, 102166. [Google Scholar] [CrossRef]
  92. Lessmann, N.; van Ginneken, B.; de Jong, P.A.; Išgum, I. Iterative fully convolutional neural networks for automatic vertebra segmentation and identification. Med. Image Anal. 2019, 53, 142–155. [Google Scholar] [CrossRef]
  93. Dzierżak, R.; Omiotek, Z. Application of Deep Convolutional Neural Networks in the Diagnosis of Osteoporosis. Sensors 2022, 22, 8189. [Google Scholar] [CrossRef]
  94. Elmahdy, M.; Sebro, R. Opportunistic Screening for Osteoporosis Using CT Scans of the Knee: A Pilot Study. Stud. Health Technol. Inform. 2023, 302, 909–910. [Google Scholar] [CrossRef]
  95. Fang, Y.; Li, W.; Chen, X.; Chen, K.; Kang, H.; Yu, P.; Zhang, R.; Liao, J.; Hong, G.; Li, S. Opportunistic osteoporosis screening in multi-detector CT images using deep convolutional neural networks. Eur. Radiol. 2021, 31, 1831–1842. [Google Scholar] [CrossRef]
  96. Huang, C.B.; Hu, J.S.; Tan, K.; Zhang, W.; Xu, T.H.; Yang, L. Application of machine learning model to predict osteoporosis based on abdominal computed tomography images of the psoas muscle: A retrospective study. BMC Geriatr. 2022, 22, 796. [Google Scholar] [CrossRef]
  97. Küçükçiloğlu, Y.; Şekeroğlu, B.; Adalı, T.; Şentürk, N. Prediction of osteoporosis using MRI and CT scans with unimodal and multimodal deep-learning models. Diagn. Interv. Radiol. 2023. [Google Scholar] [CrossRef]
  98. Löffler, M.T.; Jacob, A.; Scharr, A.; Sollmann, N.; Burian, E.; El Husseini, M.; Sekuboyina, A.; Tetteh, G.; Zimmer, C.; Gempt, J.; et al. Automatic opportunistic osteoporosis screening in routine CT: Improved prediction of patients with prevalent vertebral fractures compared to DXA. Eur. Radiol. 2021, 31, 6069–6077. [Google Scholar] [CrossRef]
  99. Naghavi, M.; De Oliveira, I.; Mao, S.S.; Jaberzadeh, A.; Montoya, J.; Zhang, C.; Atlas, K.; Manubolu, V.; Montes, M.; Li, D.; et al. Opportunistic AI-enabled automated bone mineral density measurements in lung cancer screening and coronary calcium scoring CT scans are equivalent. Eur. J. Radiol. Open 2023, 10, 100492. [Google Scholar] [CrossRef]
  100. Pan, J.; Lin, P.-C.; Gong, S.-C.; Wang, Z.; Cao, R.; Lv, Y.; Zhang, K.; Wang, L. Effectiveness of opportunistic osteoporosis screening on chest CT using the DCNN model. BMC Musculoskelet. Disord. 2023. submitted. [Google Scholar] [CrossRef]
  101. Pickhardt, P.J.; Nguyen, T.; Perez, A.A.; Graffy, P.M.; Jang, S.; Summers, R.M.; Garrett, J.W. Improved CT-based Osteoporosis Assessment with a Fully Automated Deep Learning Tool. Radiol. Artif. Intell. 2022, 4, e220042. [Google Scholar] [CrossRef]
  102. Resmi, S.L.; Hashim, V.; Mohammed, J.; Dileep, P.N. Bone Mineral Density Prediction from CT Image: A Novel Approach using ANN. Appl. Bionics Biomech. 2023, 2023, 1123953. [Google Scholar] [CrossRef]
  103. Sebro, R.; De la Garza-Ramos, C. Utilizing machine learning for opportunistic screening for low BMD using CT scans of the cervical spine. J. Neuroradiol. 2023, 50, 293–301. [Google Scholar] [CrossRef]
  104. Wang, J.; Zhou, S.; Chen, S.; He, Y.; Gao, H.; Yan, L.; Hu, X.; Li, P.; Shen, H.; Luo, M.; et al. Prediction of osteoporosis using radiomics analysis derived from single source dual energy CT. BMC Musculoskelet. Disord. 2023, 24, 100. [Google Scholar] [CrossRef]
  105. Jiang, Y.-W.; Xu, X.-J.; Wang, R.; Chen, C.-M. Radiomics analysis based on lumbar spine CT to detect osteoporosis. Eur. Radiol. 2022, 32, 8019–8026. [Google Scholar] [CrossRef]
  106. Sarker, I.H. Machine Learning: Algorithms, Real-World Applications and Research Directions. SN Comput. Sci. 2021, 2, 160. [Google Scholar] [CrossRef]
  107. Lepakshi, V.A. Machine Learning and Deep Learning based AI Tools for Development of Diagnostic Tools. In Computational Approaches for Novel Therapeutic and Diagnostic Designing to Mitigate SARS-CoV-2 Infection; Academic Press: Cambridge, MA, USA, 2022. [Google Scholar] [CrossRef]
  108. Rajkomar, A.; Dean, J.; Kohane, I. Machine Learning in Medicine. N. Engl. J. Med. 2019, 380, 1347–1358. [Google Scholar] [CrossRef] [PubMed]
  109. Hosny, A.; Parmar, C.; Quackenbush, J.; Schwartz, L.H.; Aerts, H. Artificial intelligence in radiology. Nat. Rev. Cancer 2018, 18, 500–510. [Google Scholar] [CrossRef] [PubMed]
  110. Mun, S.K.; Wong, K.H.; Lo, S.B.; Li, Y.; Bayarsaikhan, S. Artificial Intelligence for the Future Radiology Diagnostic Service. Front. Mol. Biosci. 2020, 7, 614258. [Google Scholar] [CrossRef] [PubMed]
  111. Alhajeri, M.; Aldosari, H.; Aldosari, B. Evaluating latest developments in PACS and their impact on radiology practices: A systematic literature review. Inform. Med. Unlocked 2017, 9, 181–190. [Google Scholar] [CrossRef]
  112. Gore, J.C. Artificial intelligence in medical imaging. Magn. Reson. Imaging 2020, 68, A1–A4. [Google Scholar] [CrossRef] [PubMed]
  113. Doi, K. Computer-aided diagnosis in medical imaging: Historical review, current status and future potential. Comput. Med. Imaging Graph. 2007, 31, 198–211. [Google Scholar] [CrossRef]
  114. Nagoev, Z.V.; Sundukov, Z.A.; Pshenokova, I.A.; Denisenko, V.A. Architecture of CAD for distributed artificial intelligence based on self-organizing neuro-cognitive architectures. News Kabard. Balkar. Sci. Cent. RAS 2020, 2, 40–47. [Google Scholar] [CrossRef]
  115. Kriegeskorte, N. Deep Neural Networks: A New Framework for Modeling Biological Vision and Brain Information Processing. Annu. Rev. Vis. Sci. 2015, 1, 417–446. [Google Scholar] [CrossRef]
  116. Liu, Z.; Wang, S.; Dong, D.; Wei, J.; Fang, C.; Zhou, X.; Sun, K.; Li, L.; Li, B.; Wang, M.; et al. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics 2019, 9, 1303–1322. [Google Scholar] [CrossRef]
  117. Ciresan, D.C.; Meier, U.; Masci, J.; Gambardella, L.M.; Schmidhuber, J. Flexible, high performance convolutional neural networks for image classification. In Proceedings of the Twenty-Second International Joint Conference on Artificial Intelligence, Barcelona, Spain, 16–22 July 2011. [Google Scholar]
  118. Zaharchuk, G.; Gong, E.; Wintermark, M.; Rubin, D.; Langlotz, C.P. Deep Learning in Neuroradiology. Am. J. Neuroradiol. 2018, 39, 1776–1784. [Google Scholar] [CrossRef] [PubMed]
  119. Kaka, H.; Zhang, E.; Khan, N. Artificial intelligence and deep learning in neuroradiology: Exploring the new frontier. Can. Assoc. Radiol. J. 2021, 72, 35–44. [Google Scholar] [CrossRef]
  120. Uemura, K.; Fujimori, T.; Otake, Y.; Shimomoto, Y.; Kono, S.; Takashima, K.; Hamada, H.; Takenaka, S.; Kaito, T.; Sato, Y.; et al. Development of a system to assess the two- and three-dimensional bone mineral density of the lumbar vertebrae from clinical quantitative CT images. Arch. Osteoporos. 2023, 18, 22. [Google Scholar] [CrossRef] [PubMed]
  121. Savage, R.H.; van Assen, M.; Martin, S.S.; Sahbaee, P.; Griffith, L.P.; Giovagnoli, D.; Sperl, J.I.; Hopfgartner, C.; Kärgel, R.; Schoepf, U.J. Utilizing Artificial Intelligence to Determine Bone Mineral Density Via Chest Computed Tomography. J. Thorac. Imaging 2020, 35 (Suppl. S1), S35–S39. [Google Scholar] [CrossRef] [PubMed]
  122. Pan, Y.; Shi, D.; Wang, H.; Chen, T.; Cui, D.; Cheng, X.; Lu, Y. Automatic opportunistic osteoporosis screening using low-dose chest computed tomography scans obtained for lung cancer screening. Eur. Radiol. 2020, 30, 4107–4116. [Google Scholar] [CrossRef]
  123. Tang, C.; Zhang, W.; Li, H.; Li, L.; Li, Z.; Cai, A.; Wang, L.; Shi, D.; Yan, B. CNN-based qualitative detection of bone mineral density via diagnostic CT slices for osteoporosis screening. Osteoporos. Int. 2021, 32, 971–979. [Google Scholar] [CrossRef]
  124. Breit, H.C.; Varga-Szemes, A.; Schoepf, U.J.; Emrich, T.; Aldinger, J.; Kressig, R.W.; Beerli, N.; Andreas Buser, T.; Breil, D.; Derani, I.; et al. CNN-based evaluation of bone density improves diagnostic performance to detect osteopenia and osteoporosis in patients with non-contrast chest CT examinations. Eur. J. Radiol. 2023, 161, 110728. [Google Scholar] [CrossRef]
  125. Summers, R.M.; Baecher, N.; Yao, J.; Liu, J.; Pickhardt, P.J.; Choi, J.R.; Hill, S. Feasibility of simultaneous computed tomographic colonography and fully automated bone mineral densitometry in a single examination. J. Comput. Assist. Tomogr. 2011, 35, 212–216. [Google Scholar] [CrossRef]
  126. Valentinitsch, A.; Trebeschi, S.; Kaesmacher, J.; Lorenz, C.; Löffler, M.T.; Zimmer, C.; Baum, T.; Kirschke, J.S. Opportunistic osteoporosis screening in multi-detector CT images via local classification of textures. Osteoporos. Int. 2019, 30, 1275–1285. [Google Scholar] [CrossRef]
  127. Sebro, R.; De la Garza-Ramos, C. Machine learning for the prediction of osteopenia/osteoporosis using the CT attenuation of multiple osseous sites from chest CT. Eur. J. Radiol. 2022, 155, 110474. [Google Scholar] [CrossRef]
  128. Liu, L.; Si, M.; Ma, H.; Cong, M.; Xu, Q.; Sun, Q.; Wu, W.; Wang, C.; Fagan, M.J.; Mur, L.A.J.; et al. A hierarchical opportunistic screening model for osteoporosis using machine learning applied to clinical data and CT images. BMC Bioinform. 2022, 23, 63. [Google Scholar] [CrossRef]
  129. Lim, H.K.; Ha, H.I.; Park, S.-Y.; Han, J. Prediction of femoral osteoporosis using machine-learning analysis with radiomics features and abdomen-pelvic CT: A retrospective single center preliminary study. PLoS ONE 2021, 16, e0247330. [Google Scholar] [CrossRef] [PubMed]
  130. Zhang, K.; Lin, P.; Pan, J.; Xu, P.; Qiu, X.; Crookes, D.; Hua, L.; Wang, L. End to End Multitask Joint Learning Model for Osteoporosis Classification in CT Images. Comput. Intell. Neurosci. 2023, 2023, 3018320. [Google Scholar] [CrossRef]
  131. Nam, K.H.; Seo, I.; Kim, D.H.; Lee, J.I.; Choi, B.K.; Han, I.H. Machine Learning Model to Predict Osteoporotic Spine with Hounsfield Units on Lumbar Computed Tomography. J. Korean Neurosurg. Soc. 2019, 62, 442–449. [Google Scholar] [CrossRef] [PubMed]
  132. Xu, Y.; Li, D.; Chen, Q.; Fan, Y. Full supervised learning for osteoporosis diagnosis using micro-CT images. Microsc. Res. Tech. 2013, 76, 333–341. [Google Scholar] [CrossRef] [PubMed]
  133. Krishnaraj, A.; Barrett, S.; Bregman-Amitai, O.; Cohen-Sfady, M.; Bar, A.; Chettrit, D.; Orlovsky, M.; Elnekave, E. Simulating Dual-Energy X-Ray Absorptiometry in CT Using Deep-Learning Segmentation Cascade. J. Am. Coll. Radiol. 2019, 16, 1473–1479. [Google Scholar] [CrossRef]
  134. Chen, Y.C.; Li, Y.T.; Kuo, P.C.; Cheng, S.J.; Chung, Y.H.; Kuo, D.P.; Chen, C.Y. Automatic segmentation and radiomic texture analysis for osteoporosis screening using chest low-dose computed tomography. Eur. Radiol. 2023, 33, 5097–5106. [Google Scholar] [CrossRef]
  135. Tariq, A.; Patel, B.N.; Sensakovic, W.F.; Fahrenholtz, S.J.; Banerjee, I. Opportunistic screening for low bone density using abdominopelvic computed tomography scans. Med. Phys. 2023, 50, 4296–4307. [Google Scholar] [CrossRef] [PubMed]
  136. Sollmann, N.; Löffler, M.T.; El Husseini, M.; Sekuboyina, A.; Dieckmeyer, M.; Rühling, S.; Zimmer, C.; Menze, B.; Joseph, G.B.; Baum, T.; et al. Automated Opportunistic Osteoporosis Screening in Routine Computed Tomography of the Spine: Comparison With Dedicated Quantitative CT. J. Bone Miner. Res. 2022, 37, 1287–1296. [Google Scholar] [CrossRef]
  137. Sebro, R.; De la Garza-Ramos, C. Machine Learning for Opportunistic Screening for Osteoporosis from CT Scans of the Wrist and Forearm. Diagnostics 2022, 12, 691. [Google Scholar] [CrossRef]
  138. Yoshida, K.; Tanabe, Y.; Nishiyama, H.; Matsuda, T.; Toritani, H.; Kitamura, T.; Sakai, S.; Watamori, K.; Takao, M.; Kimura, E.; et al. Feasibility of Bone Mineral Density and Bone Microarchitecture Assessment Using Deep Learning With a Convolutional Neural Network. J. Comput. Assist. Tomogr. 2023, 47, 467–474. [Google Scholar] [CrossRef] [PubMed]
  139. Dai, H.; Wang, Y.; Fu, R.; Ye, S.; He, X.; Luo, S.; Jin, W. Radiomics and stacking regression model for measuring bone mineral density using abdominal computed tomography. Acta Radiol. 2023, 64, 228–236. [Google Scholar] [CrossRef] [PubMed]
  140. Naghavi, M.; Atlas, K.; Jaberzadeh, A.; Zhang, C.; Manubolu, V.; Li, D.; Budoff, M. Validation of Opportunistic Artificial Intelligence-based Bone Mineral Density Measurements in Coronary Artery Calcium Scans. J. Am. Coll. Radiol. 2023, in press. [Google Scholar] [CrossRef] [PubMed]
  141. Xue, Z.; Huo, J.; Sun, X.; Sun, X.; Ai, S.T.; Zhang, L.; Liu, C. Using radiomic features of lumbar spine CT images to differentiate osteoporosis from normal bone density. BMC Musculoskelet. Disord. 2022, 23, 336. [Google Scholar] [CrossRef] [PubMed]
  142. Qiu, H.; Yang, H.; Yang, Z.; Yao, Q.; Duan, S.; Qin, J.; Zhu, J. The value of radiomics to predict abnormal bone mass in type 2 diabetes mellitus patients based on CT imaging for paravertebral muscles. Front. Endocrinol. 2022, 13, 963246. [Google Scholar] [CrossRef]
  143. Mookiah, M.R.K.; Rohrmeier, A.; Dieckmeyer, M.; Mei, K.; Kopp, F.K.; Noel, P.B.; Kirschke, J.S.; Baum, T.; Subburaj, K. Feasibility of opportunistic osteoporosis screening in routine contrast-enhanced multi detector computed tomography (MDCT) using texture analysis. Osteoporos. Int. 2018, 29, 825–835. [Google Scholar] [CrossRef]
  144. Lee, S.J.; Binkley, N.; Lubner, M.G.; Bruce, R.J.; Ziemlewicz, T.J.; Pickhardt, P.J. Opportunistic screening for osteoporosis using the sagittal reconstruction from routine abdominal CT for combined assessment of vertebral fractures and density. Osteoporos. Int. 2016, 27, 1131–1136. [Google Scholar] [CrossRef]
  145. Johannesdottir, F.; Allaire, B.; Bouxsein, M.L. Fracture Prediction by Computed Tomography and Finite Element Analysis: Current and Future Perspectives. Curr. Osteoporos. Rep. 2018, 16, 411–422. [Google Scholar] [CrossRef]
  146. Dagan, N.; Elnekave, E.; Barda, N.; Bregman-Amitai, O.; Bar, A.; Orlovsky, M.; Bachmat, E.; Balicer, R.D. Automated opportunistic osteoporotic fracture risk assessment using computed tomography scans to aid in FRAX underutilization. Nat. Med. 2020, 26, 77–82. [Google Scholar] [CrossRef]
  147. Roux, C.; Rozes, A.; Reizine, D.; Hajage, D.; Daniel, C.; Maire, A.; Bréant, S.; Taright, N.; Gordon, R.; Fechtenbaum, J.; et al. Fully automated opportunistic screening of vertebral fractures and osteoporosis on more than 150 000 routine computed tomography scans. Rheumatology 2022, 61, 3269–3278. [Google Scholar] [CrossRef]
  148. Graffy, P.M.; Lee, S.J.; Ziemlewicz, T.J.; Pickhardt, P.J. Prevalence of Vertebral Compression Fractures on Routine CT Scans According to L1 Trabecular Attenuation: Determining Relevant Thresholds for Opportunistic Osteoporosis Screening. Am. J. Roentgenol. 2017, 209, 491–496. [Google Scholar] [CrossRef]
  149. Pickhardt, P.J.; Graffy, P.M.; Zea, R.; Lee, S.J.; Liu, J.; Sandfort, V.; Summers, R.M. Automated Abdominal CT Imaging Biomarkers for Opportunistic Prediction of Future Major Osteoporotic Fractures in Asymptomatic Adults. Radiology 2020, 297, 64–72. [Google Scholar] [CrossRef]
  150. Watts, N.B. The Fracture Risk Assessment Tool (FRAX®): Applications in clinical practice. J. Womens Health 2011, 20, 525–531. [Google Scholar] [CrossRef] [PubMed]
  151. Turečková, A.; Tureček, T.; Komínková Oplatková, Z.; Rodríguez-Sánchez, A. Improving CT Image Tumor Segmentation Through Deep Supervision and Attentional Gates. Front. Robot. AI 2020, 7, 106. [Google Scholar] [CrossRef]
  152. Herrmann, P.; Busana, M.; Cressoni, M.; Lotz, J.; Moerer, O.; Saager, L.; Meissner, K.; Quintel, M.; Gattinoni, L. Using Artificial Intelligence for Automatic Segmentation of CT Lung Images in Acute Respiratory Distress Syndrome. Front. Physiol. 2021, 12, 1484. [Google Scholar] [CrossRef]
  153. Paudyal, R.; Shah, A.D.; Akin, O.; Do, R.K.G.; Konar, A.S.; Hatzoglou, V.; Mahmood, U.; Lee, N.; Wong, R.J.; Banerjee, S.; et al. Artificial Intelligence in CT and MR Imaging for Oncological Applications. Cancers 2023, 15, 2573. [Google Scholar] [CrossRef] [PubMed]
  154. Park, C.W.; Oh, S.J.; Kim, K.S.; Jang, M.C.; Kim, I.S.; Lee, Y.K.; Chung, M.J.; Cho, B.H.; Seo, S.W. Artificial intelligence-based classification of bone tumors in the proximal femur on plain radiographs: System development and validation. PLoS ONE 2022, 17, e0264140. [Google Scholar] [CrossRef]
  155. Ong, W.; Zhu, L.; Tan, Y.L.; Teo, E.C.; Tan, J.H.; Kumar, N.; Vellayappan, B.A.; Ooi, B.C.; Quek, S.T.; Makmur, A.; et al. Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review. Cancers 2023, 15, 1837. [Google Scholar] [CrossRef] [PubMed]
  156. Hallinan, J.T.P.D.; Zhu, L.; Zhang, W.; Lim, D.S.W.; Baskar, S.; Low, X.Z.; Yeong, K.Y.; Teo, E.C.; Kumarakulasinghe, N.B.; Yap, Q.V.; et al. Deep Learning Model for Classifying Metastatic Epidural Spinal Cord Compression on MRI. Front. Oncol. 2022, 12, 1479. [Google Scholar] [CrossRef]
  157. Engelke, K. Quantitative Computed Tomography-Current Status and New Developments. J. Clin. Densitom. 2017, 20, 309–321. [Google Scholar] [CrossRef]
  158. Lee, S.; Chung, C.K.; Oh, S.H.; Park, S.B. Correlation between Bone Mineral Density Measured by Dual-Energy X-Ray Absorptiometry and Hounsfield Units Measured by Diagnostic CT in Lumbar Spine. J. Korean Neurosurg. Soc. 2013, 54, 384–389. [Google Scholar] [CrossRef]
  159. Wang, L.; Su, Y.; Wang, Q.; Duanmu, Y.; Yang, M.; Yi, C.; Cheng, X. Validation of asynchronous quantitative bone densitometry of the spine: Accuracy, short-term reproducibility, and a comparison with conventional quantitative computed tomography. Sci. Rep. 2017, 7, 6284. [Google Scholar] [CrossRef]
  160. Wang, Y.; Zhang, Z.; Cai, N.; Zhou, Y.; Xiao, D. A Prediction Model for the Risk of Osteoporosis Fracture in the Elderly Based on a Neural Network. In Proceedings of the Advances in Neural Networks–ISNN 2018: 15th International Symposium on Neural Networks, ISNN 2018, Minsk, Belarus, 25–28 June 2018; Springer International Publishing: Cham, Switzerland, 2018; pp. 815–823. [Google Scholar]
  161. Yu, X.; Ye, C.; Xiang, L. Application of artificial neural network in the diagnostic system of osteoporosis. Neurocomputing 2016, 214, 376–381. [Google Scholar] [CrossRef]
  162. Beaudoin, C.; Moore, L.; Gagné, M.; Bessette, L.; Ste-Marie, L.G.; Brown, J.P.; Jean, S. Performance of predictive tools to identify individuals at risk of non-traumatic fracture: A systematic review, meta-analysis, and meta-regression. Osteoporos. Int. 2019, 30, 721–740. [Google Scholar] [CrossRef]
  163. Klinder, T.; Ostermann, J.; Ehm, M.; Franz, A.; Kneser, R.; Lorenz, C. Automated model-based vertebra detection, identification, and segmentation in CT images. Med. Image Anal. 2009, 13, 471–482. [Google Scholar] [CrossRef] [PubMed]
  164. Anderst, W.J.; Thorhauer, E.D.; Lee, J.Y.; Donaldson, W.F.; Kang, J.D. Cervical spine bone mineral density as a function of vertebral level and anatomic location. Spine J. 2011, 11, 659–667. [Google Scholar] [CrossRef]
  165. Johannesdottir, F.; Allaire, B.; Kopperdahl, D.L.; Keaveny, T.M.; Sigurdsson, S.; Bredella, M.A.; Anderson, D.E.; Samelson, E.J.; Kiel, D.P.; Gudnason, V.G.; et al. Bone density and strength from thoracic and lumbar CT scans both predict incident vertebral fractures independently of fracture location. Osteoporos. Int. 2021, 32, 261–269. [Google Scholar] [CrossRef] [PubMed]
  166. Bauer, J.S.; Henning, T.D.; Müeller, D.; Lu, Y.; Majumdar, S.; Link, T.M. Volumetric quantitative CT of the spine and hip derived from contrast-enhanced MDCT: Conversion factors. Am. J. Roentgenol. 2007, 188, 1294–1301. [Google Scholar] [CrossRef] [PubMed]
  167. Cummings, S.R.; Black, D.M.; Nevitt, M.C.; Browner, W.; Cauley, J.; Ensrud, K.; Genant, H.K.; Palermo, L.; Scott, J.; Vogt, T.M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993, 341, 72–75. [Google Scholar] [CrossRef]
  168. Melton, L.J., 3rd; Looker, A.C.; Shepherd, J.A.; O’Connor, M.K.; Achenbach, S.J.; Riggs, B.L.; Khosla, S. Osteoporosis assessment by whole body region vs. site-specific DXA. Osteoporos. Int. 2005, 16, 1558–1564. [Google Scholar] [CrossRef]
  169. Kanis, J.A. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002, 359, 1929–1936. [Google Scholar] [CrossRef] [PubMed]
  170. Guglielmi, G.; Muscarella, S.; Bazzocchi, A. Integrated imaging approach to osteoporosis: State-of-the-art review and update. Radiographics 2011, 31, 1343–1364. [Google Scholar] [CrossRef] [PubMed]
  171. Zou, D.; Li, W.; Deng, C.; Du, G.; Xu, N. The use of CT Hounsfield unit values to identify the undiagnosed spinal osteoporosis in patients with lumbar degenerative diseases. Eur. Spine J. 2019, 28, 1758–1766. [Google Scholar] [CrossRef] [PubMed]
  172. Oheim, R.; Tsourdi, E.; Seefried, L.; Beller, G.; Schubach, M.; Vettorazzi, E.; Stürznickel, J.; Rolvien, T.; Ehmke, N.; Delsmann, A.; et al. Genetic Diagnostics in Routine Osteological Assessment of Adult Low Bone Mass Disorders. J. Clin. Endocrinol. Metab. 2022, 107, e3048–e3057. [Google Scholar] [CrossRef] [PubMed]
  173. Adejuyigbe, B.; Kallini, J.; Chiou, D.; Kallini, J.R. Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics. Int. J. Mol. Sci. 2023, 24, 14583. [Google Scholar] [CrossRef] [PubMed]
  174. Jain, S.; Camacho, P. Use of bone turnover markers in the management of osteoporosis. Curr. Opin. Endocrinol. Diabetes Obes. 2018, 25, 366–372. [Google Scholar] [CrossRef] [PubMed]
  175. Biver, E.; Chopin, F.; Coiffier, G.; Brentano, T.F.; Bouvard, B.; Garnero, P.; Cortet, B. Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis. Jt. Bone Spine 2012, 79, 20–25. [Google Scholar] [CrossRef]
  176. Gillett, M.J.; Vasikaran, S.D.; Inderjeeth, C.A. The Role of PINP in Diagnosis and Management of Metabolic Bone Disease. Clin. Biochem. Rev. 2021, 42, 3–10. [Google Scholar] [CrossRef]
  177. Greenblatt, M.B.; Tsai, J.N.; Wein, M.N. Bone Turnover Markers in the Diagnosis and Monitoring of Metabolic Bone Disease. Clin. Chem. 2017, 63, 464–474. [Google Scholar] [CrossRef]
  178. Kusec, V. Biochemical markers of bone turnover—Clinical application and limitations. Lijec. Vjesn. 2005, 127, 139–145. [Google Scholar]
  179. Lee, J.; Vasikaran, S. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann. Lab. Med. 2012, 32, 105–112. [Google Scholar] [CrossRef] [PubMed]
  180. Bhattoa, H.P. Laboratory aspects and clinical utility of bone turnover markers. Ejifcc 2018, 29, 117–128. [Google Scholar] [PubMed]
  181. Shetty, S.; Kapoor, N.; Bondu, J.D.; Thomas, N.; Paul, T.V. Bone turnover markers: Emerging tool in the management of osteoporosis. Indian. J. Endocrinol. Metab. 2016, 20, 846–852. [Google Scholar] [CrossRef] [PubMed]
  182. Saxena, S.; Jena, B.; Gupta, N.; Das, S.; Sarmah, D.; Bhattacharya, P.; Nath, T.; Paul, S.; Fouda, M.M.; Kalra, M.; et al. Role of Artificial Intelligence in Radiogenomics for Cancers in the Era of Precision Medicine. Cancers 2022, 14, 2860. [Google Scholar] [CrossRef]
  183. Bodalal, Z.; Trebeschi, S.; Nguyen-Kim, T.D.L.; Schats, W.; Beets-Tan, R. Radiogenomics: Bridging imaging and genomics. Abdom. Radiol. 2019, 44, 1960–1984. [Google Scholar] [CrossRef] [PubMed]
  184. Ren, M.; Yang, H.; Lai, Q.; Shi, D.; Liu, G.; Shuang, X.; Su, J.; Xie, L.; Dong, Y.; Jiang, X. MRI-based radiomics analysis for predicting the EGFR mutation based on thoracic spinal metastases in lung adenocarcinoma patients. Med. Phys. 2021, 48, 5142–5151. [Google Scholar] [CrossRef] [PubMed]
  185. Fan, Y.; Dong, Y.; Yang, H.; Chen, H.; Yu, Y.; Wang, X.; Wang, X.; Yu, T.; Luo, Y.; Jiang, X. Subregional radiomics analysis for the detection of the EGFR mutation on thoracic spinal metastases from lung cancer. Phys. Med. Biol. 2021, 66, 215008. [Google Scholar] [CrossRef]
  186. Xu, R.; You, T.; Liu, C.; Lin, Q.; Guo, Q.; Zhong, G.; Liu, L.; Ouyang, Q. Ultrasound-based radiomics model for predicting molecular biomarkers in breast cancer. Front. Oncol. 2023, 13, 1216446. [Google Scholar] [CrossRef]
  187. European Society of Radiology (ESR). The new EU General Data Protection Regulation: What the radiologist should know. Insights Imaging 2017, 8, 295–299. [Google Scholar] [CrossRef]
  188. Candemir, S.; Nguyen, X.V.; Folio, L.R.; Prevedello, L.M. Training Strategies for Radiology Deep Learning Models in Data-limited Scenarios. Radiol Artif Intell. 2021, 3, e210014. [Google Scholar] [CrossRef]
  189. Eche, T.; Schwartz, L.H.; Mokrane, F.-Z.; Dercle, L. Toward Generalizability in the Deployment of Artificial Intelligence in Radiology: Role of Computation Stress Testing to Overcome Underspecification. Radiol. Artif. Intell. 2021, 3, e210097. [Google Scholar] [CrossRef] [PubMed]
  190. Orlhac, F.; Boughdad, S.; Philippe, C.; Stalla-Bourdillon, H.; Nioche, C.; Champion, L.; Soussan, M.; Frouin, F.; Frouin, V.; Buvat, I. Orlhac F, Boughdad S, Philippe C, Stalla-Bourdillon H, Nioche C, Champion L, et al. A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET. J. Nucl. Med. 2018, 59, 1321–1328. [Google Scholar] [CrossRef] [PubMed]
  191. Johnson, A.E.W.; Pollard, T.J.; Shen, L.; Lehman, L.-w.H.; Feng, M.; Ghassemi, M.; Moody, B.; Szolovits, P.; Celi, L.A.; Mark, R.G. MIMIC-III, a freely accessible critical care database. Sci. Data 2016, 3, 160035. [Google Scholar] [CrossRef] [PubMed]
  192. Olson, R.S.; La Cava, W.; Orzechowski, P.; Urbanowicz, R.J.; Moore, J.H. PMLB: A large benchmark suite for machine learning evaluation and comparison. BioData Min. 2017, 10, 36. [Google Scholar] [CrossRef] [PubMed]
  193. Harutyunyan, H.; Khachatrian, H.; Kale, D.C.; Ver Steeg, G.; Galstyan, A. Multitask learning and benchmarking with clinical time series data. Sci. Data 2019, 6, 96. [Google Scholar] [CrossRef]
  194. van Timmeren, J.E.; Cester, D.; Tanadini-Lang, S.; Alkadhi, H.; Baessler, B. Radiomics in medical imaging-“how-to” guide and critical reflection. Insights Imaging 2020, 11, 91. [Google Scholar] [CrossRef]
  195. Kotter, E.; Ranschaert, E. Challenges and solutions for introducing artificial intelligence (AI) in daily clinical workflow. Eur. Radiol. 2021, 31, 5–7. [Google Scholar] [CrossRef]
  196. Recht, M.P.; Dewey, M.; Dreyer, K.; Langlotz, C.; Niessen, W.; Prainsack, B.; Smith, J.J. Integrating artificial intelligence into the clinical practice of radiology: Challenges and recommendations. Eur. Radiol. 2020, 30, 3576–3584. [Google Scholar] [CrossRef]
Figure 1. PRISMA flowchart for the literature search (this is adapted from the PRISMA group, 2020), which describes the selection of relevant articles.
Figure 1. PRISMA flowchart for the literature search (this is adapted from the PRISMA group, 2020), which describes the selection of relevant articles.
Bioengineering 10 01364 g001
Figure 2. Diagram illustrating the hierarchical structure of artificial intelligence. Machine learning, a subset of artificial intelligence, is a discipline that imparts computers with the capacity to learn autonomously, bypassing the need for explicit programming. Within the realm of machine learning, deep learning represents a subset that enables the computation of neural networks with multiple layers. CNN is a subset of deep learning characterized by convolutional layers.
Figure 2. Diagram illustrating the hierarchical structure of artificial intelligence. Machine learning, a subset of artificial intelligence, is a discipline that imparts computers with the capacity to learn autonomously, bypassing the need for explicit programming. Within the realm of machine learning, deep learning represents a subset that enables the computation of neural networks with multiple layers. CNN is a subset of deep learning characterized by convolutional layers.
Bioengineering 10 01364 g002
Figure 3. Diagram showing the general framework and main steps of radiomics, namely data selection (input), segmentation, feature extraction in the regions of interest (ROIs), exploratory analysis, and modeling.
Figure 3. Diagram showing the general framework and main steps of radiomics, namely data selection (input), segmentation, feature extraction in the regions of interest (ROIs), exploratory analysis, and modeling.
Bioengineering 10 01364 g003
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ong, W.; Liu, R.W.; Makmur, A.; Low, X.Z.; Sng, W.J.; Tan, J.H.; Kumar, N.; Hallinan, J.T.P.D. Artificial Intelligence Applications for Osteoporosis Classification Using Computed Tomography. Bioengineering 2023, 10, 1364. https://doi.org/10.3390/bioengineering10121364

AMA Style

Ong W, Liu RW, Makmur A, Low XZ, Sng WJ, Tan JH, Kumar N, Hallinan JTPD. Artificial Intelligence Applications for Osteoporosis Classification Using Computed Tomography. Bioengineering. 2023; 10(12):1364. https://doi.org/10.3390/bioengineering10121364

Chicago/Turabian Style

Ong, Wilson, Ren Wei Liu, Andrew Makmur, Xi Zhen Low, Weizhong Jonathan Sng, Jiong Hao Tan, Naresh Kumar, and James Thomas Patrick Decourcy Hallinan. 2023. "Artificial Intelligence Applications for Osteoporosis Classification Using Computed Tomography" Bioengineering 10, no. 12: 1364. https://doi.org/10.3390/bioengineering10121364

APA Style

Ong, W., Liu, R. W., Makmur, A., Low, X. Z., Sng, W. J., Tan, J. H., Kumar, N., & Hallinan, J. T. P. D. (2023). Artificial Intelligence Applications for Osteoporosis Classification Using Computed Tomography. Bioengineering, 10(12), 1364. https://doi.org/10.3390/bioengineering10121364

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop